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ABSTRACT
PAS Kinase and TOR, Controllers of Cell Growth and Proliferation
Brooke Jasmyn Cozzens
Department of Microbiology and Molecular Biology, BYU
Master of Science
Nutrient sensing kinases lie at the heart of cellular health and homeostasis, allowing cells
to quickly adapt to changing environments. Target of Rapamycin (TOR) and PAS kinase
(PASK, or PASKIN) are two such nutrient kinases, conserved from yeast to man. In yeast, these
kinases each have paralogs. The two TOR paralogs in yeast mimic the mammalian TORC1 and
TORC2 complexes, except both Tor1 and Tor2 may contribute to TORC1 or TORC2 function.
The two PAS kinase paralogs are paired with the TOR paralogs, meaning that both Psk1 and
Psk2 regulate TORC1, while Psk2 suppresses a temperature-sensitive allele of Tor2. Herein we
review the evolutionary models for these paralogs, their function in yeast and mammalian cells,
as well as the overlapping function of PAS kinase and TOR. We also use Rice University’s
Direct Coupling Analysis algorithms to analyze co-evolutionary relationships and identify
potential interaction sites between PAS kinase and several of its substrates.

Keywords: PAS kinase, gene duplication, mTOR, TORC1, TORC2, glucose metabolism, signal
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SPECIFIC AIMS
1. Publish a review article on the co-evolution of PAS kinase and TOR.
2. Perform Direct Coupling Analysis on PAS kinase and Ugp1, Cbf1, Utr1, USF1, and
ATXN2 to determine potential phosphosites and PASK-substrate interaction sites.
A) Collect sequences for orthologs of each of these proteins in mammals and yeast
species.
B) Align sequences and perform DCA on supercomputer.
C) Analyze data and select residues for mutation (based on highest mutual information
coefficients and PASK consensus sequences).
D) Design primers for site-directed mutagenesis, create constructs, and sequence
plasmids for verification of mutation.
E) Perform kinase assays to determine if selected residues are critical for PASKsubstrate interactions, or if they are key phosphosites.
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CHAPTER 1: Project Introduction
Different models exist for how proteins have evolved over time. Early scientists believed
that the human genome contained a large number of base pairs that served no purpose and were
evidence of “nature’s failed experiments,” [1] however, we now know that is much too simplistic
of an explanation. It is more likely that certain proteins had side activities that conferred no
selective advantage or disadvantage, but over time, cellular environments changed, and the side
activity became advantageous [2]. Through amplification, divergence, and possible
recombination, genes with new functions can emerge. One of the most amazing parts of nature
is how different proteins/systems in the cell have evolved to work together, regulating key
pathways, including: cellular metabolism, cell growth and proliferation, translational control,
cellular stress, etc. This study will focus on the conserved pathways and co-evolution of two
important sensory kinases – Per-Arnt-Sim kinase (PASK) and Target of Rapamycin (TOR).
1.1 Importance of PASK and TOR
Sensory protein kinases play a critical role in the health of a cell, phosphorylating many
proteins and allowing them to control several critical metabolic functions, including cellular
growth and proliferation. PAS kinase, a recently discovered sensory protein kinase in yeast, is
one of these important sensory kinases that is highly conserved from yeast to humans, and plays
an essential role in cellular metabolism [3]. PAS kinase contains both a catalytic kinase domain
and a regulatory PAS domain. PAS domains are sensory domains that regulate protein activity
by binding small molecules or proteins [4], while the kinase domain regulates other proteins via
phosphorylation at a serine or threonine. To prevent the kinase domain from phosphorylating
and activating/ inactivating substrates needlessly, the PAS domain binds the kinase domain to
inhibit its catalytic activity [5]. PAS kinase regulates several important substrates, including the
2

serine-threonine kinase termed TOR (Target of Rapamycin), which has the effect of decreasing
cell growth and proliferation [6]. TOR kinase forms two complexes in humans - mammalian
TOR complex 1 (mTORC1) and mammalian TOR complex 2 (mTORC2), which are composed
of several different proteins. The functions of the two TOR complexes overlap on some roles,
but mTORC1 primarily controls cell expansion and proliferation [7], whereas mTORC2 controls
metabolism [8] and the restructuring of the cytoskeleton [9]. Yeast also have two TOR
complexes, TORC1 and TORC2, and their roles are highly conserved. Similar to PAS kinase in
yeast, the genes encoding the TOR kinases in yeast are believed to be a result of a whole-genome
duplication in an early ancestor. The main components of TORC1 work together to control
protein synthesis in response to growth factors and nutrients [10]. The main components of
TORC2 regulate cell survival, cell cycle progression, and metabolism by phosphorylating and
activating other effector kinases, and it’s also involved in actin organization during cell division
[11].
1.2 Co-evolution of PAS Kinase and TOR
We are particularly interested in studying PAS kinase and TOR because PASK-knockout
mice were hypermetabolic and more resistant to liver triglyceride accumulation than the
wildtype, despite having similar exercise levels. Because of its tie to cellular metabolism, PASK
could potentially serve as a therapeutic target for cancer and diabetes. When TOR is inhibited, it
has also been shown to extend lifespan in S. cerevisiae, C. elegans, and D. melanogaster [12-14].
PAS kinase and TOR appear to have co-evolved to work together in the cell to regulate various
cellular processes. PAS kinase and TOR have many overlaps in function, including their roles in
regulating translation initiation. The two paralogs in yeast - PAS kinase and TOR - appear to
have paired function. One of the primary functions of TORC1 in yeast is to modulate translation
3

initiation. TORC1 consists of either Tor1 or Tor2 together with Kog1, Lst8 and Tco89. TORC1
is inhibited by both Psk1 and Psk2p through the phosphorylation and activation of Pbp1, which
in turn sequesters TORC1 to stress granules, inhibiting growth and proliferation [15]. In
contrast, Psk2 regulates cell division (cytoskeleton polarization and cell wall integrity) through
the activation of RhoI, suppressing lethality due to TORC2 deficiency [16]. Thus, both TOR and
PAS kinase have overlapping functions for their paralogs (Tor1 and Tor2, Psk1 and Psk2) in cell
growth and proliferation, and specific functions for Tor2 and Psk2 in cytoskeletal polarization
and cell integrity. These roles for PAS kinase in TORC1 regulation and the suppression of
TORC2 deficiency by Psk2 remain unstudied in mammalian cells.
1.3 Difficulty of Identifying Interaction Sites
Notwithstanding the vital importance of protein kinases within the cell, they can be
difficult to study. Protein-kinase interactions are generally highly transient, so typical proteinprotein interaction discovery methods, such as co-immunoprecipitation and mass spectrometry,
rarely give the full “protein-kinase interaction picture.” In addition to the transient nature of
these interactions, there are often multiple sites which are phosphorylated on a target protein,
often by multiple kinases, so understanding the regulation and functions of these proteins can be
a difficult, but very important task because of the critical cellular processes involved. The sheer
number of proteins phosphorylated in the cell – 30-50%, depending on needs in the body – also
complicates the study of protein kinases [17]. The sheer quantity of kinases and their multitude
of targets makes them mechanistically difficult to study. Kinases often phosphorylate multiple
sites on its substrates, and PAS kinase is no exception, further complicating the identification of
critical phosphorylation sites. Kinases often induce conformational changes when they
phosphorylate their substrates, effectively “hiding” the phosphosite on the inside of the protein
4

and potentially changing how the substrate interacts with other proteins in the cell, including its
location in the cell [18]. Structure affects function in proteins, so proteins are commonly
crystallized to better understand how they could interact with their substrates, however, large
proteins such as PAS kinase are difficult to crystallize [19].
1.4 Purpose of this Project
Because of the difficulty in studying kinase-substrate interactions, we propose a novel
method of studying protein kinases and their phosphosites using Rice University’s Direct
Coupling Analysis (DCA) algorithms [20] with PAS kinase and five of its known substrates as a
case study. Using DCA, the co-evolution of PASK with its confirmed substrates Cbf1, Ugp1,
Utr1, USF1, and ATXN2 is estimated by Mutual Information, allowing us to predict the most
likely interaction points or phosphosites for the proteins. We can potentially predict sites that are
not captured by current kinase-study techniques, allowing us to be more thorough in our
research, and then use site-directed mutagenesis of the sites predicted by DCA to confirm
cellular effects caused by PAS kinase. Using DCA, we will explore the co-evolutionary
relationships between PASK and TOR, as well as several other substrates in yeast and
mammalian species.
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CHAPTER 2: Evolution of TOR and PAS Kinase by Gene Duplication
Abstract
Nutrient sensing kinases lie at the heart of cellular health and homeostasis, allowing cells
to quickly adapt to changing environments. Target of Rapamycin (TOR) and PAS kinase
(PASK, or PASKIN) are two such nutrient kinases, conserved from yeast to man. In yeast, these
kinases each have paralogs. The two TOR paralogs in yeast mimic the mammalian TORC1 and
TORC2 complexes, except both Tor1 or Tor2 may contribute to TORC1 and TORC2 function.
The two PAS kinase paralogs are paired with the TOR paralogs, meaning that both Psk1 and
Psk2 regulate TORC1, while Psk2 suppresses a temperature-sensitive allele of Tor2. Herein we
review the evolutionary models for these paralogs, their function in yeast and mammalian cells,
as well as the overlapping function of PAS kinase and TOR.
2.1 Introduction
The complexity of life has led to the advancement of diverse evolutionary models,
including models that address the molecular details for how proteins evolve over time. Early
scientists believed that the human genome contained a large number of base pairs that served no
purpose and were evidence of “nature’s failed experiments,” [1] however, this explanation is
much too simplistic. It is more likely that certain proteins had side activities that conferred no
selective advantage or disadvantage, but over time, cellular environments changed, and the side
activity became advantageous [2]. Through amplification, divergence, and possible
recombination, genes with new functions can emerge. In this review, we focus on two key
nutrient-sensing kinases, Per-Arnt-Sim kinase (PASK) and Target of Rapamycin (TOR), that
have paralogs which evolved by gene duplication to have unique, but related functions in the
cell.
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Protein kinases like PASK and TOR play critical roles in cellular health and homeostasis,
particularly in response to changing environments where posttranslational control of several
proteins allows for concerted adaptation of multiple pathways. Protein kinases are able to
regulate other proteins in the cell through phosphorylation. This regulation can alter cellular
activity by affecting the substrate’s function in various ways, including modulating activity,
stability, cellular localization, and/or binding partners [21]. They often have tens of substrates,
allowing them to regulate multiple pathways simultaneously and potentially drastically
reprogramming cellular metabolism. In fact, up to half of the eukaryotic proteome is
phosphorylated, illustrating the importance of kinases in the cell [17, 22]. It is, therefore, no
surprise that protein kinases are highly conserved from yeast to man and lie at the heart of many
diseases such as diabetes and cancer [23]. Nutrient sensing kinases are a large class of protein
kinases that respond to cellular nutrient status (such as glucose, amino acid, or ATP availability).
Not only do PASK and TOR have paralogs that have evolved to have important, unique
functions in the cell, but the kinases have also evolved to work together. In other words, Psk1
and Tor2 have evolved to work together in different pathways than Psk2 and Tor1 [16], while
still retaining many functional overlaps in the cell. We will discuss the evolutionary and
functional similarities between PASK and TOR, and how their paralogs/complexes have evolved
to work together in distinct, yet interrelated, cellular pathways.
2.2 Evolution of Proteins by Gene Duplication and Recombination
Ohno hypothesized that there was a strict upper limit for the number of working genes
that could be supported in a genome. He suggested that the human genome contained evidence
of “nature’s failed experiments,” and the extra base pairs were simply “junk DNA.” Ohno
claimed that excess genetic material arose in DNA when point mutations negatively affecting the
7

active sites of gene products accumulated and were thus eliminated by natural selection, but the
inefficient or nonfunctional genes still remained as empty base pairs that did not code for any
proteins. He additionally argued that in order for advantageous mutations to occur, the selective
pressure of natural selection had to be temporarily removed by polyploidization or by tandem
duplication [1] (see Figure 2-1). This rather basic explanation for the emergence of new genes
likely does not provide the whole picture. On the route to becoming a gene with a new function,
copies of the parent gene must also overcome genetic drift, mutation, recombinational
segregation, gene conversion, and avoid being counter selected due to metabolic cost or a
negative alteration of gene dosage [24].

(A)

(B)

Figure 2-1. Two Models for Gene Evolution by Duplication.
(A) Ohno’s Model: a) progenitor gene; b) gene duplication and divergence/mutation; c) new gene
emerges with a distinct function that’s advantageous; d) progenitor gene is no longer useful to the cell. (B)
IAD Model: a) original gene; b) original protein with a side activity (e.g. TOR with the side activity of
rapamycin resistance) that is advantageous; c) gene duplication, allowing for mutations; d) two separate
proteins result – efficient original protein and an efficient side activity protein; d) recombination may then
occur, producing: f) a novel protein that is efficient at both the original activity and side activity.
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A more accurate model for the evolution of paralogous genes may be the innovation,
amplification, and divergence (IAD) model proposed by Bergthorsson, Andersson and Roth,
which allows for selection at every step of the process [2]. The main idea behind this model is
that the original gene encodes a protein that provides a primary function, along with another
minor activity that does not confer any selective advantage or disadvantage. Over time,
conditions around the cell may change and contain a toxic compound or altered nutrient
availability, and one of the side activities may then become advantageous in the new
environment. The gene with enhanced side activity will then be selected for and duplicated,
wherein large expanded arrays of the duplication containing multiple gene copies may form,
providing more opportunities for an advantageous mutation to occur. As one of the copies is
enhanced by mutation, selective pressure on the other copies is more relaxed and the gene
expansions may collapse. Eventually there will be a copy that is efficient at the original activity
and another copy that is efficient at the side activity. Through recombination, the best of the
original activity and side activity can be combined and a new gene with a novel function emerges
[2].
The evolution of TOR and PAS kinase appear to both have been influenced by gene
duplication. Two paralogs of PAS kinase and TOR exist in yeast, while many eukaryotes encode
only one PAS kinase or TOR protein. Although there is only one protein, mammalian TOR
(mTOR) forms two complexes, TORC1 and TORC2, which harbor analogous functions to the
two yeast paralogs TOR1 and TOR2 [25].
The yeast paralogs, Psk1 and Psk2, appear to have different yet overlapping roles. The
occurrence of two PAS kinase and TOR paralogs in yeast most likely arose from a wholegenome duplication of an early ancestor, and protein complexes that share subunits like TOR can
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provide a selective reason for maintaining duplicate copies of the shared subunits [26-31]. Most
of the duplicated genome would have been lost due to random mutation, loss of activity and
deselection; however, genes which acquired new, important, functions could be selected for.
Below, we will discuss the common ancestry and important, interrelated functions of the Target
of Rapamycin (TOR) and Per-Arnt-Sim kinase (PASK) pathways in yeast and mammals.
2.3 Target of Rapamycin (TOR) in Yeast and Mammals
TOR is an evolutionarily conserved protein that exists in many species, including yeast,
flies, and mammals. TOR was first discovered in the budding yeast S. cerevisiae through the
characterization of mutations that allowed the cells to grow in the presence of the usually
growth-inhibiting compound rapamycin. Upon entering the cell, rapamycin binds to FK506binding protein of 12 kDa (FKBP12) and interacts with the FKBP12-rapamycin binding domain
(FRB) of mTOR, therefore inhibiting mTORC1 function [32, 33]. TOR is part of a complex web
of interacting proteins that work together to help cells respond to their external and internal
environments. Increased TOR activity in mammalian cells has been linked to a decreased ability
to deal with cellular stress and faster age progression, as well as increased cancer risk [34]. TOR
is responsible for controlling cell growth in response to nutrients and growth factors [35]. As
stated earlier, the presence of two TOR genes in both budding and fission yeast may have
occurred by gene duplication. Eventually, the two TORs acquired specific functions. In other
yeast genera and organisms including mammals, there is only one TOR gene. Nonetheless,
mammalian TOR can form two distinct protein complexes, mTORC1 and mTORC2, similar to
its yeast counterparts (Figure 2-2).
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Figure 2-2. Mammalian TOR Can Form Two Distinct Protein Complexes, mTORC1 and
mTORC2, Similar to its Yeast Counterparts.
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2.4 Conserved Subunits of TOR Complexes in Mammals
In mammals and budding yeast, the signaling complex TORC1 regulates the cellular
response to nutrients [36] and has several conserved domains important for its function. mTOR
contains HEAT repeats (Huntingtin, Elongation Factor 3, A subunit of PP2A (protein
phosphatase 2A), TOR1), followed by the FAT (FRAP (FKBP12-rapamycin-associated
protein)/TOR, ATM (ataxia-telangiectasia), TRRAP (transactivation/transformation-domainassociated protein)) and FATC (FAT C-terminal) domains, which are important for mTOR’s
catalytic kinase activity. Mutations in these domains, which domains may also play a role in the
folding of the kinase domain [37], eliminates mTOR-dependent phosphorylation of 4E-BP
(eukaryotic initiation factor 4E-binding protein) and S6K (S6 kinase), as well as mTOR
autophosphorylation activity [38-40]. The FATC domain also has a critical, conserved cysteine
residue that when modified, causes decreased TOR levels [41]. Neighboring the conserved
kinase domain of mTOR is the FRB (FKBP12/rapamycin-binding) domain, where rapamycin (in
complex with FKBP12) binds and inhibits mTOR. Interestingly, the FRB can bind phosphatidic
acid, a lipid that is speculated to mediate membrane localization of mTOR [42-45], a key feature
of TOR function.
The TOR complexes not only include the critical TOR protein, but also contain many
other conserved subunits (see Table 2-1 for a summary of these proteins and their conservation
in humans and yeast). In mTORC1, the complex includes mTOR (conserved), RAPTOR
(conserved), and LST8 (conserved), as well as the close interactors, PRAS40, TSC1/2, and Rheb.
In mammals, RAPTOR binds to mTOR [7, 25, 46] and is thought to serve as a scaffold to
present substrates to mTOR but does not alter the catalytic activity of mTOR. RAPTOR also
causes sensitivity to rapamycin, and possibly nutrients [7, 47]. RAPTOR is considered an
12

essential gene since no viable knockout mice were obtained when heterozygous intercrosses of
RAPTOR+/− mice were performed (similar to mTOR+/− mice) [48, 49], which also provides an
explanation for its conservation across species.

Table 2-1. Conservation of the TOR Complex Proteins in Select Eukaryotes.

LST8, another important conserved subunit of mTORC1, is necessary for transporting
amino acid permeases from the Golgi to the cell surface [50, 51] (LST8 localizes to endosomal
or Golgi membranes [52]). LST8 mutants have an abnormal growth phenotype, but this
phenotype can be suppressed with the chaperonin protein CCT6 (chaperonin containing TCP-1),
supporting the idea that mTORC1 is involved in protein folding and stabilization [53]. mLST8 is
capable of binding to mTOR and RAPTOR when they are overexpressed [25, 54]. When bound
to the kinase domain of mTOR, mLST8 stimulates its kinase activity [54]. On its own, mLST8’s
association with mTOR is not able to stimulate nutrient sensitivity, but it is required for the
nutrient-sensitive interaction of RAPTOR to mTOR. mLST8 plays a role in the recognition and
recruitment of substrates to mTOR, but it is also conjectured to be involved in the stability and
folding of the mTOR kinase domain [54].
13

PRAS40 (proline-rich Akt substrate of 40 kDa), although not technically part of the “core
proteins” of the conserved mTORC1 complex, is also important because it binds and negatively
regulates mTORC1 [55-60]. PRAS40 physically interferes and directly inhibits the binding of
substrates to mTOR and is phosphorylated by mTORC1 in a rapamycin-sensitive fashion [57].
Akt (also known as PKB) phosphorylates PRAS40 to negatively regulate it, therefore promoting
mTORC1 activity [58].
In contrast to mTORC1, relatively little is known about mTORC2’s function and biology.
In mammals, growth factors and/or hormonal signals appear to regulate mTORC2 [61, 62].
mTOR forms a separate complex with unique functionality, termed mTORC2. mTORC2 is
composed of mTOR (conserved), RICTOR (conserved), LST8 (conserved), SIN1 (conserved),
and a close interactor protein PROTOR (also called PRR5). Although similar in structure to
mTORC1, mTORC2 is considered to be resistant to rapamycin because rapamycin cannot bind
to the mTORC2 complex. However, this resistance model may be an oversimplification since
continued exposure to rapamycin has been shown to inhibit the assembly of the mTORC2
complex [63]. Despite a lack of understanding, mTORC2 is no less important than mTORC1;
mTORC2 plays a key part in various biological processes, including: cellular respiration and
lifespan, cytoskeleton polarization, cellular stress, and salt balance.
PROTOR (protein observed with RICTOR), also called PRR5 (proline-rich protein 5), is
an interacting partner of mTORC2. It binds to RICTOR independently of mTOR, even while
RICTOR is actively bound to mTOR [64, 65]. The function of PROTOR is unknown, but it may
be involved in PDGFR (platelet-derived-growth-factor receptor) signaling [64]. A PROTORlike protein which regulates apoptosis, was also found to bind mTORC2 [60]. However,
PROTOR is not required for the binding of other mTORC2 subunits, including RICTOR and
14

SIN1, but may mediate other unknown mTORC2 functions. Also, PROTOR knockdown does
not significantly reduce phosphorylation of Akt at Ser473 [64], further suggesting that PROTOR
may not be necessary for mTORC2 function. SIN1 is essential for phosphorylation and
activation of certain AGC-family kinases but is not required for TOR’s catalytic activity (TOR
may phosphorylate substrates in vitro, despite a lack of SIN1). In the Shiozaki lab, it was
recently shown that the substrate specificity of TORC2 is determined by the ubiquitin-fold
domain of the SIN1 subunit [66].
2.5 The Regulation of TORC1 and TORC2 in Mammals
Because TOR and many other subunits of the TOR complexes are highly conserved
across species and act in a wide variety of pathways to control cellular metabolism, it comes as
no surprise that diseases often result when they are dysregulated. Below, we will discuss several
regulators of TOR (summarized in Table 2-2), followed by cellular pathways/ functions affected
by TOR (summarized in Table 2-3).

Table 2-2. A Summary of the Known Pathways/Proteins that Regulate TOR in the Mammalian and Yeast Cells.

Regulator
Rapamycin
Growth Factors
(amino acids,
glucose, etc);
Hormonal Signals
(insulin, etc.); High
ATP:AMP ratio
PROTOR (PRR5)

TOR*

Mechanism/ Function

Ref.

mTORC1/TORC1,
mTORC2/TORC2
mTORC2

Inhibitory, but affects TORC1
more than TORC2
mTORC2 responds to different
signals to regulate many cellular
processes

[32, 33, 63]

mTORC2

Unknown function and not
required, but interacts with
mTORC2 and may be involved
with PDGFR signaling

[64]
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[62, 67]

SIN1/AVO1

Rheb/Rhb1
TSC1/2
Akt (PKB)
PRAS40
RAPTOR;
KOG1/Mip1

LST8/Wat1

Rag Proteins

DNA Damage/ p53
RICTOR/AVO3
TCO89

mTORC2/TORC2

Regulates substrate specificity;
Essential for phosphorylation of
certain AGC kinases; Actin
polarization
mTORC1/TORC1
Directly binds TOR (in mTORC1)
and TOR2 (in TORC1) to promote
its activity
mTORC1/spTORC1 Negative regulator; Conveys the
presence of insulin; GTPase
inactivator of Rheb/Rhb1
mTORC1
Negatively regulates PRAS40 to
promote mTORC1 activity
mTORC1
Binds and negatively regulates
mTORC1 by interfering with
substrate binding
mTORC1
Essential; Serves as a scaffold to
present substrates; Sensitive to
rapamycin; KOG1/Mip1 function
has not been shown in vivo, but
they are orthologous to RAPTOR
mTORC1/TORC1,
Important for recognition and
mTORC2/TORC2
recruitment of substrates;
Stimulates transportation of amino
acid permeases to cell surface;
Stimulates kinase activity;
Required for nutrient-sensitive
interaction of RAPTOR+mTOR;
Proper localization of F-actin
mTORC1
Necessary and sufficient for
sensing cellular nutrients and
moving mTORC1 to lysosomal
surface; Promotes localization of
mTORC1 to areas containing its
activator Rheb
mTORC1/spTORC1 Activation of p53 activates
AMPK, which activates TSC2 (see
above)
mTORC2/scTORC2 Required for TORC2 structural
integrity
scTORC1
Associates with TORC1, but may
operate independently

[25, 66]

[58, 68]
[58, 68-71]
[58]
[55-60]
[7, 25, 46,
48, 49]

[50, 51, 54,
72]

[73, 74]

[75]
[76]
[10, 77]

* The prefix “sc” or “sp” means the protein only exists or has only been studied in S. cerevisiae or S. pombe. If the
protein is mammalian, it has the prefix “m.”
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In mammals, mTOR is part of the complexes TORC1 and TORC2. Because mTORC1 is
considered a nutrient-sensing kinase, it is controlled and activated by a high ATP:AMP cellular
energy level, growth factors such as insulin, and nutrients such as amino acids and glucose. In
mammals, several pathways convey the presence of growth signals, such as insulin, to mTORC1
via regulation of TSC1/TSC2 [69]. The tuberous sclerosis complex (TSC), which is composed of
TSC1 and TSC2, is one of the most important regulators of mTORC1. The TSC complex
functions as a GTPase-activating protein (GAP) for the GTPase Rheb (see Table 2-2). The
active form of Rheb directly interacts with mTORC1 to promote its activity [68, 78], while
TSC1/2 serve as negative regulators of mTORC1 by converting Rheb into its inactive GDPbound state [70, 71]. Stimulation of this TSC pathway increases the phosphorylation of TSC2 by
Akt [79, 80] and leads to the inactivation of the TSC complex, and consequently to the activation
of mTORC1. Also, Akt activation by growth factors can activate mTORC1 by promoting the
phosphorylation and dissociation of PRAS40 from mTORC1 [56, 78, 81]. A very important role
of mTORC1 is sensing the energy status and needs of the cell. In response to energy depletion,
AMPK is activated and phosphorylates TSC2, which increases its activity toward Rheb, reducing
mTORC1 activation [79]. AMPK can also reduce mTORC1 activity directly by phosphorylating
RAPTOR when there’s a low ATP:AMP ratio [82]. Mild hypoxia is also capable of activating
AMPK and inhibiting mTORC1 [83, 84]. Inflammatory mediators also communicate with
mTORC1 via the TSC1/2 complex. Pro-inflammatory cytokines (such as TNF) activate IkB
kinase-b (IKKb), which interacts with and inactivates TSC1, leading to mTORC1 activation [85].
This relationship between inflammation and mTORC1 activation is thought to be correlated with
tumor angiogenesis [85], as well as the development of insulin resistance [86]. mTORC1 is also
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capable of responding to amino acids. In the presence of amino acids, Rag proteins bind to
RAPTOR and promote mTORC1’s localization to areas containing its activator Rheb [73].
Until the work of Yasemin Sancak, it was unknown how mTORC1 was able to sense
nutrients, such as growth factors, intracellular energy levels, and amino acid availability; she
found that heterodimeric Rag GTPases interacted with mTORC1 when amino acids and other
nutrients stimulated the cell [73]. In fact, Rag GTPases were found to be necessary and sufficient
for mTORC1 to sense amino acids [73, 74]. To further understand the function of mTORC1,
knock-in mice with a constitutively active RagA allele were generated, but this mutation was
found to cause the mice to die during periods of fasting because they were unable to switch from
an anabolic to a catabolic state (due to mTORC1 remaining active despite nutritional starvation)
[87]. Using immunofluorescent antibodies, it was determined that mTORC1 localized to

lysosomes, but nutrient availability (made known by the Rag GTPases) signaled mTORC1 to
move to the surface of the lysosome [73, 74, 87, 88].
Mammalian TORC1 is also capable of responding to amino acids. In the presence of
elevated amino acid levels, Rag proteins bind to RAPTOR and promote mTORC1’s localization
to areas containing its activator Rheb [73]. LST8, another important conserved subunit of
mTORC1, is necessary for transporting amino acid permeases from the Golgi to the cell surface
[50, 51] (LST8 localizes to endosomal or Golgi membranes [52]). LST8 mutants have an
abnormal growth phenotype, but this phenotype can be suppressed by overexpressing the
chaperonin protein CCT6 (chaperonin containing TCP-1), supporting the idea that mTORC1 is
involved in protein folding and stabilization [53]. mLST8 is capable of binding to mTOR and
RAPTOR when they are overexpressed [25, 54]. When bound to the kinase domain of mTOR,
mLST8 stimulates its kinase activity [54]. On its own, the association of mLST8 with mTOR is
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not able to stimulate nutrient sensitivity, but it is required for the nutrient-sensitive interaction of
RAPTOR to mTOR. mLST8 plays a role in the recognition and recruitment of substrates to
mTOR, but it is also conjectured to be involved in the stability and folding of the mTOR kinase
domain [54].
DNA damage also stimulates mTORC1 activation. For instance, the activation of p53 in
response to DNA damage rapidly activates AMPK through an unknown process, which in turn
phosphorylates and thereby activates TSC2 [75].

Table 2-3. A Summary of the Known In Vivo Effects of TOR in Yeast and Mammalian Cells.

Protein*

TOR

Mech.*

Apparent effect

mS6K

mTORC1

mAKT (PKB)
mJNK
scYpk1/2

mTORC2
mTORC2
scTORC1/2

scSch9

scTORC1

mIRS1

mTORC1

m4E-BP
scSfp1

mTORC1
scTORC1

mPKM2

mTORC2

Wide-Range Effects
DP
protein synthesis/translation, mRNA
processing, glucose homeostasis, cell
growth, and survival
UK
cell survival, substrate specificity
DB
cell survival, T-cell differentiation
DP
cell growth, translation initiation, actin
organization, cell integrity
DP
lifespan, cell growth, stress response
Pancreatic Function
DP
decreased stability when
phosphorylated
Translational Control
DP
promotes cap-dependent translation
DP
activation; increased ribosome
biosynthesis
Respiration Control
DP
upregulation

mcPKC

mTORC2

UK

spSAPK

spTORC2

scRim15

scTORC1

glycogenolysis, gluconeogenesis
Stress Response
UK
activation of stress response to multiple
stressors
Lifespan
DP
increases lifespan
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Ref.
[89]
[61, 62]
[90-92]
[93, 94]
[95-98]
[99,
100]
[101]
[102]
[103,
104]
[105]
[90-92]
[106]

mMEKK2

mTORC2

Cellular Signaling
DB
cellular signaling

[91]

*The abbreviation “sc” is for Saccharomyces cerevisiae and “sp” is for Schizosaccharomyces pombe, meaning
that the data comes from studies with yeast proteins in yeast, while “m” is for mammalian proteins and “x” is for
both yeast and mammalian proteins. DP is for direct phosphorylation, DB is for direct binding, UK is unknown.
This table excludes in vitro substrates that have been identified but may lack in vivo evidence.

2.6 The Functions of TORC1 in Mammals
2.6.1 Pancreatic Function. It has recently been shown that mTORC1 is closely linked to
-cell development in utero and during the neonatal period, and thus may be tied to Type 2
Diabetes (T2D) and obesity in adulthood [107-109]. In fact, mTOR inhibitors are already on the
market for the treatment of certain types of cancers [110], where they were found to cause a high
incidence of new-onset diabetes, ranging from 13 to 50% [111]. mTORC1 is also capable of
activating ribosomal protein S6 kinase -1 (S6K1) by phosphorylating insulin receptor substrate
1 (IRS1) and reducing its stability, which has important implications for metabolic diseases [99,
100].
2.6.2 Cellular Respiration and Lifespan. Although mTOR inhibitors can have the
negative side effect of increasing the likelihood of diabetes, decreased mTOR activity has been
shown to increase lifespan in S. cerevisiae, C. elegans, and D. melanogaster [12-14]. The
mTOR inhibitor rapamycin has also been shown to increase lifespan in mice [112, 113]. It is
proposed that mTOR signaling may increase with age especially in adipose tissue, but if it is
inhibited by rapamycin, lifespans may lengthen [114]. The free radical concept of aging [115]
says that reactive oxygen species damage mitochondria, and therefore reduce ATP output, which
in turn inhibits the mTOR pathway [116]. Decreased mTOR upregulates glycolysis [117] and
downregulates autophagy [115]. This downregulation of autophagy can also indirectly support
tumor growth.
20

2.6.3 Translational Control. The central function of mTORC1 is to regulate the
intracellular metabolic state by shifting from catabolism to promoting the synthesis of proteins,
lipids, and nucleotides [118, 119]. mTORC1 is capable of regulating its substrate S6 kinase
(S6K). S6K has been linked to diverse cellular processes, including: protein
synthesis/translation, mRNA processing, glucose homeostasis, cell growth, and survival.
Interestingly, S6K contains a TOR-signaling (TOS) motif [89], suggesting a co-evolutionary
relationship between the TORCs and S6K. Depending on the activation state of S6K (a complex
process, involving multiple proteins), it can associate with different regulatory complexes. In its
inactive state, it binds eukaryotic initiation factor 3 (eIF3) [120]. However, upon cellular
stimulation, mTOR/RAPTOR binds to eIF3, then subsequently phosphorylates S6K at Thr389.
When S6K is phosphorylated by mTOR, it dissociates from the eIF3– mTORC1 complex, thus
becoming available to phosphorylate its downstream targets. These findings raise the possibility
that the activity of mTOR/RAPTOR is dependent on the signaling complex it associates with and
on the cellular compartment it localizes to. mTOR can also phosphorylate the translational
regulator 4E-BP [101]. 4E-BP has no enzymatic activity, but the small regulatory protein can be
phosphorylated at multiple residues in a rapamycin-sensitive fashion to promote cap-dependent
translation. 4E-BP contains a common recognition motif, TOS (TOR signaling), which is also
found in S6K [89], which could explain why mTOR is capable of phosphorylating such
structurally distinct proteins.
Through these conserved proteins/pathways, mTORC1 is able to positively regulate cell
growth and proliferation by promoting many anabolic processes (i.e. biosynthesis of proteins,
lipids, and organelles) and by limiting catabolic processes (such as autophagy). mTOR is highly
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conserved (Table 2-1), and even the functions of the pathway are highly similar between yeast
and man (see Table 2-3 summary).
2.7 The Functions of TORC2 in Mammals
2.7.1 Cellular Respiration and Lifespan. TOR is also able to influence cell survival,
growth, proliferation, and migration through the activity of Akt. Three Akt genes have been
identified in mammals: Akt1 (PKBα), Akt2 (PKBβ), and Akt3 (PKBγ) [121]. mTOR, along with
several other kinases (DNA protein kinase (DNA-PK), integrin-linked kinase (ILK), ATM,
cPKC, and Akt itself), has been identified as a PDK2 (the term for a kinase that phosphorylates
the hydrophobic motif site of Akt) [122-126] that phosphorylates the hydrophobic motif site of
Akt [127]. Phosphorylation of the hydrophobic motif by mTOR (as well as other PDK2 kinases)
is induced by growth factors such as insulin and is sensitive to PI3K inhibitors such as
wortmannin. mTORC2 promotes phosphorylation of Ser473 in vitro in a serum-inducible and
wortmannin-sensitive manner [61, 128], though there are several ideas for how Akt is regulated
in the cell [128-130]. Interestingly, Ser473 phosphorylation is highly inducible in vivo by
growth-factor or serum stimulation, but its induction in vitro using the immunoprecipitated
mTOR complex is not as apparent. There could be several reasons for this discrepancy,
however, it is possible that negative regulators of the mTOR complex were inhibiting mTOR
activity in the assays [58]. Additional in vivo evidence for the TOR regulation of Akt is that the
knockdown of the mTORC2 component RICTOR, but not the mTORC1 component RAPTOR,
led to defective phosphorylation of Akt at Ser473 [61]. Genetic studies of MEFs with deficient
mTORC components confirmed that mTORC2 is required for hydrophobic motif site
phosphorylation. In RICTOR-, mLST8- or SIN1-knockout cells, Ser473 phosphorylation was
completely eliminated. Akt remained partly active in mTORC2-disrupted cells and
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phosphorylated a subset of its known substrates but was defective in the phosphorylation of
Foxo1/3a (apoptosis-promoting proteins) [62]. These findings suggest that the phosphorylation
of Ser473 may play a role in cell survival and that hydrophobic motif site phosphorylation may
regulate substrate specificity in Akt. mTOR may not directly phosphorylate Akt, but mTORC2
may facilitate autophosphorylation, activate other kinases, mediate cellular
compartmentalization, or even inhibit phosphatases (as has been shown in other yeast studies
[131]) to control these complex and inter-dependent regulatory pathways.
It has also been suggested that mTOR may play a role in the phosphorylation of cPKC, a
kinase important for gluconeogenesis, glycogenolysis [105], and endothelial permeability [132].
In the Sarbassov study, knockdown of RICTOR and mTOR expression revealed diminished
phosphorylation of cPKCα [9]. In RICTOR-, SIN1-, and mLST8-knockout cells,
phosphorylation of cPKCα at the hydrophobic motif site (Ser657) was eliminated, but it was also
accompanied by a dramatic reduction in cPKCα protein expression [48]. However, the decrease
in cPKCα expression was not evident in RICTOR-knockdown cells [9].
Interestingly, mTORC2 can also contribute to the Warburg effect seen in cancerous cells,
where they tend to prefer metabolism via aerobic glycolysis rather than the more efficient
oxidative phosphorylation, because mTORC2 upregulates the glycolytic enzyme PKM2 [103].
2.7.2 Cytoskeleton Polarization. One of the central components of mTORC2 is
RICTOR. In mammals, knocking down the highly conserved RICTOR protein leads to defects
in both actin cytoskeleton organization and in the phosphorylation of two AGC kinases - cPKCα
(conventional protein kinase Cα) and Akt (PKB) - at their hydrophobic motif sites [9, 61, 72].
Predictably, RICTOR knockout is embryonic lethal [48, 133, 134]. However, MEFs (murine
embryonic fibroblasts) isolated from null embryos did not show any noteworthy defects in actin
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cytoskeleton nor morphology, but the growth rate of RICTOR- cells was slower than wildtype
MEFs [133].
An important conserved protein included in mTORC2 is LST8. mLST8, in addition to its
nutrient-sensing and amino acid transporting functions in mTORC1, also functions as part of
mTORC2 to support the reorganization of the actin cytoskeleton. Knockdown of mLST8 leads
to defects in actin cytoskeleton reorganization when fibroblasts are stimulated with serum [72].
Additionally, more recent studies using mLST8-knockout cells have shown that mLST8 is
required for mTORC2, but not mTORC1 functions [48].
2.7.3 Cellular Stress. Mammalian SIN1 is another important component of mTORC2
that is conserved [62, 133]. It has been shown that knocking out mSIN1 leads to embryonic
lethality, loss of TORC2 complex formation, as well as loss of kinase activity [62, 134]. In
mammals, at least five alternatively spliced isoforms of SIN1 could be generated [91, 135], three
of which are capable of forming distinct mTORC2 complexes [136]. Most SIN1 orthologs
contain a conserved Raf-like RBD (Ras-binding domain) and Pleckstrin Homology (PH) domain,
but the exact functions of these domains in vivo is unknown [137]. In mammals, Sin1 binds JNK
(c-Jun N-terminal kinase) and MEKK2 (MAPK -mitogen-activated protein kinase/ERK extracellular-regulated-protein kinase- kinase kinase 2). JNK is responsive to many different
types of stimuli, including cytokines, ultraviolet radiation, osmotic shock, and heat shock. Once
activated, JNK plays a role in T-cell differentiation and apoptosis, possibly implying new
functions of mTORC2 signaling. SIN1 binding MEKK2 is also important in cellular signaling
[90-92].
2.7.4 Salt Balance. A direct-interaction relationship between SGK and mTOR has not
been confirmed yet, but it’s likely that an interaction occurs since SGK’s structure is highly
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similar to that of Akt [138]. Three SGK paralogs exist in mammals and mainly function to
regulate salt balance by activating ion channels, ion carriers, and the Na+ /K+ - ATPase. SGK is
highly regulated on multiple levels, including its expression, its kinase activity, and its
subcellular localization [139]. SGK also phosphorylates other substrates involved in stress
responses, with some of the targets overlapping with Akt substrates. Interestingly, rapamycin
treatment does not block the hyperphosphorylation of SGK upon serum stimulation [140],
suggesting that mTORC2 may mediate phosphorylation.
2.8 Conserved Subunits of TOR Complexes in Yeast
Similar to mammals, yeast TOR complexes are controlled by different nutrients,
stressors, and amino acids within the cell. Below, we will discuss several pathways affected by
TOR in yeast and the important cellular processes that they control. The conservation of TOR
complexes (that exist in both budding and fission yeast) will also be reviewed. In budding yeast,
TOR is encoded by two different genes, TOR1 and TOR2, distinguishing it from mammalian
TOR complexes. TOR1 is part of TORC1, while TOR2 is a component of both TORC1 and
TORC2 in budding yeast. In the absence of TOR1, TOR2 can substitute in TORC1, which
explains why deletion of TOR1 is nonlethal but a deletion of TOR2 is lethal [36].
In addition to TOR, TORC1 in budding yeast such as S. cerevisiae, is composed of LST8
(orthologous to Wat1), KOG1 (orthologous to RAPTOR and Mip1), and an interactor protein
called TCO89 (see Figure 2-2). In fission yeast such as S. pombe, TORC1 includes TOR2, while
TOR1 or TOR2 can be part of TORC2. TORC1 in fission yeast also includes Mip1 (orthologous
to KOG1 and RAPTOR) and Wat1 (orthologous to LST8). Consistent with the conserved nature
of these proteins, TORC1 in mammals, budding yeast, and fission yeast, are all responsive to
nutrient conditions [141, 142]. The similarities to mammals don’t stop there - fission yeast in
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TORC1 is controlled by Tsc1/Tsc2 (where Tsc is tuberous sclerosis complex) via negative
regulation of the GTPase Rhb1 [143, 144]. The tuberous sclerosis complexes do not have
orthologs in budding yeast, however, a Rheb ortholog (RHB1) that is capable of promoting
TORC1 activity exists [145, 146]. Whether RHB1 still regulates TOR in budding yeasts, even
with a lack of TSCs, remains to be investigated. Differently from humans, rapamycin does not
inhibit TORC1 in fission yeast during vegetative growth but appears to affect some of the
TORC2-dependent functions [147, 148].
KOG1 (an essential gene product containing four internal HEAT repeats and seven Cterminal WD40 repeats) copurifies with TOR1 [25]. In fact, it was shown in S. cerevisiae that
the HEAT repeats that are part of TOR form a curved tubular-shaped domain that associates with
the C-terminal WD40 repeat domain of KOG1 (kontroller of growth 1), a “core protein” of
budding yeast’s TORC1 [38]. KOG1’s counterpart in fission yeast is Mip1 in TORC1 [141,
142].
In budding yeast, AVO3 (orthologous to RICTOR and Ste20) is required for TORC2
structural integrity but is nonessential for the kinase activity of TOR2 in vitro [76]. AVO3
mutations suppress csg2 mutants which excessively accumulate sphingolipids [149]. Because of
this fact, TORC2 may be involved in sphingolipid metabolism or signaling, since the TORC2
effectors SLM1/2 (synthetic lethal with MSS4 1/2) are targets of sphingolipid signaling during
heat stress [150-153]. S. pombe Ste20 (orthologous to RICTOR and AVO3, but different from S.
cerevisiae STE20) binds Tor1 more strongly than Tor2 when it’s overexpressed [141], but in S.
cerevisiae, Tor1 is a subunit of TORC2, which illustrates conservation of function across
species.
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LST8, a subunit which is conserved from humans to yeast, is a critically important part of
both TORC1 and TORC2 and is capable of binding the kinase domain of TOR2 [76]. In fission
yeast, the LST8 ortholog Wat1 binds both Tor1 and Tor2 [141, 142] and is required for proper
localization of F-actin [154], although another study found that neither TORC1 nor TORC2 play
a significant role in actin organization in fission yeast [141].
TCO89 (TOR complex one 89 kDa subunit) is the product of a yeast-specific nonessential gene in S. cerevisiae. Although it is not conserved across species, TCO89 is still
interesting because it shows the flexibility of the TOR complexes, while still maintaining the
critical “core proteins” that are conserved across species throughout evolutionary history.
TCO89 associates with TORC1, but it also localizes to distinct vacuolar structures and is
believed to also operate independently of TORC1 [10, 77].
TORC2 is also highly conserved and shares similar structure and proposed functions to
mammalian TORC2. In fission yeast, TORC2 is required for responses to starvation, sexual
development, and stress conditions [155, 156], but is also required for cell integrity under
different stressors [150, 157]. Interestingly, in a two-hybrid screen, FKBP12 was shown to be
capable of binding Tor1 (a component of TORC2) in the presence of rapamycin [148].
However, similarly to mammals, TORC2 in budding yeast in not very sensitive to rapamycin
[147].
TORC2 in budding yeast is composed of TOR (conserved), LST8 (orthologous to Wat1),
AVO1 (orthologous to SIN1), and AVO3 (orthologous to RICTOR and Ste20), with protein
interactors, including: AVO2, BIT61, BIT2, and SLM 1/2. The TORC2 complex of fission yeast
includes TOR (conserved), Wat1 (orthologous to LST8), Sin1 (orthologous to AVO1), and Ste20
(orthologous to RICTOR and AVO3) [141]. In yeast, TOR2 performs a crucial function that
27

cannot be replaced by TOR1, since TOR2 can replace TOR1 in the complexes if necessary, but
the opposite is not true [36].
2.9 The Regulation of TORC1 and TORC2 in Yeast
Because the TOR complex sequences are highly conserved from yeast to man, many of
the functions are consistent as well. Rapamycin is still capable of inhibiting the TOR complexes,
and similarly to humans, TORC1 is more sensitive to the compound than TORC2 [32, 33, 63].
LST8 in S. cerevisiae (conserved, called Wat1 in S. pombe) regulates both TORC1 and TORC2
and is important for recognition and recruitment of substrates, stimulates transportation of amino
acid permeases to the cell’s surface, stimulates the kinase activity of TOR, and influences the
proper localization of F-actin in the cytoskeleton. Although LST8/Wat1 is not required for the
phosphorylation ability of the TOR complexes, it is required for the nutrient-sensitive interaction
of RAPTOR (yeast orthologs are KOG1 and Mip1) and mTOR [50, 51, 54, 72]. Rhb1, the
ortholog of human Rheb, is responsible for binding TORC1 and promoting its activity [58, 68].
TSC1/2 exists in humans and S. pombe; it serves as a negative regulator of spTORC1 [58, 6871]. It has also been shown that DNA damage, specifically p53, is capable of activating AMPK,
which then activates TSC2 and negatively regulates spTORC1 [75]. TCO89 associates with
scTORC1, so it may be involved with its regulation, however, it may also be able to operate
independently [10, 77].
AVO1, a non-conserved interactor protein of TORC2 in S. cerevisiae, is capable of
regulating substrate specificity of the complex, is essential for the phosphorylation of certain
AGC kinases by TOR, and influences actin polarization in the cell [25, 66]. It was also shown
that AVO3 in S. cerevisiae is important for regulating the structural integrity of scTORC2 [76].
2.10 The Functions of TORC1 in Yeast
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2.10.1 Cellular Respiration and Lifespan. SCH9 is required for longevity and cell size in
budding yeast [97, 98]. The closest mammalian ortholog of SCH9 is Akt, but is has also been
shown to be functionally similar to S6K [95]. Six of the seven phosphorylated residues at the Cterminus of SCH9 that occur in vivo, are nutrient- and rapamycin- sensitive, suggesting they are
regulated by TORC1 [95] (it has also been shown that TORC1 directly phosphorylates at least
five of the phosphosites in vitro). The phosphorylation of these residues is essential for SCH9
function, since mutation of these sites abolishes in vitro kinase activity of SCH9 [95]. When
TORC1 activates SCH9 by direct phosphorylation, it can then inhibit Rim15 by direct
phosphorylation [106]. They found that treatment of yeast cells with caffeine releases Rim15
from TORC1‐SCH9‐mediated inhibition and consequently increases lifespan. Because this
kinase cascade is evolutionarily conserved, it suggests that caffeine may extend lifespan in other
eukaryotes, including humans [106]. SCH9 is predominantly located at the vacuolar membrane
[158], and since the vacuole is an important reservoir of nutrients in yeast, TORC1 and/or SCH9
may play a role in sensing and/or remobilization of intracellular nutrients as well [95].
2.10.2 Cellular Stress. SCH9 may also play a role in the transcriptional activation of
genes that are essential for osmotic stress responses [96]. It has been shown that SCH9
phosphorylation is reduced following osmotic, oxidative or thermal stress [95]. This stress
response function of SCH9 is dependent on the MAPK HOG1 (high osmolarity glycerol
response 1) and the ATF (activating transcription factor)/CREB (cAMP-response-elementbinding protein) transcription factor SKO1 [96].
There is evidence that TORC1 controls the response to saline stress in the cell. The Hall
lab showed that transcription of ENA1, a gene encoding a lithium and sodium ion transporter, is
essential for salt tolerance in yeast and is controlled by the TOR signaling cascade [159]. Under
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TOR-activating conditions, ENA1 expression is strongly induced. The absence of the TORcontrolled GATA transcription factors GLN3 and GAT1 also results in reduced basal and saltinduced expression of ENA1. In the same study, the Hall lab also showed that a gln3
gat1 mutant displayed a marked sensitivity to high concentrations of lithium and sodium. TOR1,
similar to ENA1, is required for growth under saline stress conditions. Because of this, it is
believed that TOR plays a role in the general response to saline stress by regulating the
transcription of ENA1 via GLN3 and GAT1 [159].
YPK1/2 (yeast protein kinase) have close homology with mammalian SGK (serum- and
glucocorticoid inducible kinase) and Akt. YPK1/2 can be functionally replaced by SGK, and
partially by Akt1 [160]. When YPK1 was deleted, it resulted in a slow growth phenotype and
rapamycin hypersensitivity, while the loss of YPK2 showed no obvious defect [93, 161]. When
wildtype cells were starved for nitrogen, YPK1 itself is rapidly degraded, and YPK-deficient
cells exhibit translation initiation arrest. Deletion of both YPK1/2 is lethal, suggesting they may
have overlapping functions in the cell [93]. All of this together suggests that YPK may be part
of a nutrient-sensing pathway that regulates translation initiation and that TORC1 (which is
rapamycin-sensitive) is a regulator of YPK; however, administering rapamycin does not affect
the kinase activity and expression levels of YPK [93]. It is likely that there is significant
crosstalk between TORC1 and TORC2, because other studies suggest TORC2 is the regulator of
YPK. In a TOR2-deficient cell line, a 5′-truncated version of YPK2 was capable of rescuing the
cells [94]. Interestingly, mutation of a conserved sequence in the N-terminal region of YPK2
suppressed the defective actin organization of a tor2 mutant and the impaired phosphorylation of
MPK1, a downstream effector of TOR2 in the cell-integrity pathway (the N-terminal sequence
negatively regulates YPK activity). Furthermore, TORC2 can phosphorylate YPK2 in vitro and
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this phosphorylation is decreased when suspected interaction sites are mutated, suggesting that
these sites are targeted by TORC2 [94]. We also know that YPK1 and TORC2 act in the same
regulatory pathway, because overexpression of the RHO1-GEF (RHO1-guanine-nucleotideexchange factor), TUS1, suppresses YPK or tor2 mutants [162, 163].
2.10.3 Ribosomal Biogenesis and Translational Control. TORC1 binds and directly
phosphorylates the Split Zn-finger transcription factor Sfp1 to promote its binding to a subset of
ribosomal protein gene promoters. This protein cascade presumably regulates the nuclear
localization and/or binding to ribosomal proteins and possibly gene promoters to stimulate their
expression. Interestingly, unlike Sch9, Sfp1 phosphorylation by TORC1 appears to be
unaffected by osmotic or nutritional stress, suggesting that TORC1 regulates these substrates by
very different mechanisms [102].
2.10.4 Amino Acid Synthesis and the Retrograde Response. TORC1 is also known to
control the transcription factors GLN3, RTG1, and RTG3, all of which are known to mediate
glutamine synthesis. When glutamine synthetase inhibitor L-methionine sulfoximine (MSX)
was added, it provoked glutamine depletion in the yeast cells, causing nuclear localization and
activation of GLN3, RTG1, and RTG3, which are normally inhibited by TOR [164].
TORC1 also regulates the subcellular localization of the Rtg1/Rtg3 transcription factor
complex through an indirect mechanism. Results of an epistasis analyses suggest that Rtg2 and
Mks1 act downstream of TOR and upstream of Rtg1 and Rtg3 [165]. The Powers lab also
demonstrated that TOR negatively regulates a concise cluster of genes (termed RTG target
genes) that encode mitochondrial and peroxisomal enzymes required for de novo amino acid
biosynthesis. In order to localize to the nucleus, it requires the cytoplasmic protein Rtg2. It is
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believed that the likely role of Rtg2 is to antagonize the activity of Mks1, which is a negative
regulator of RTG target gene activation [165].
2.11 The Functions of TORC2 in Yeast
2.11.1 Cytoskeleton Polarization. In budding yeast, AVO1 (orthologous to Sin1) binds to
yeast TORC2. Lowering expression of AVO1 in yeast leads to actin depolarization, a phenotype
that is also seen in Tor2 mutants [25]. Sin1 binds S. pombe SAPK (stress-activated protein
kinase) [90-92], which may explain a few of its downstream effects on regulating the cell’s
response to different stressors.
Although nonessential, TORC2 also physically interacts with AVO2 and BIT61 [10, 25].
The complete function of the interaction is unknown, but BIT61 can associate with SLM1 and
SLM2, two proteins that mediate TORC2 responses to stressors such as heat, oxidation, and actin
cytoskeleton formation/organization [151-153, 157, 166]. TOR2 has been linked to the
phosphorylation of the SLMs in vivo and in vitro, however, it may not be a direct regulatory
effect [151, 157]. By describing the known structures and functions of these interacting proteins,
we can see how critically important the conservation of this system is to the health and viability
of cells across many distinct species.
2.11.2 Lipid Biosynthesis. In budding yeast, AVO3 (orthologous to RICTOR and Ste20)
is required for TORC2 structural integrity but is nonessential for the kinase activity of TOR2 in
vitro [76]. AVO3 mutations suppress csg2 mutants which excessively accumulate sphingolipids
[149]. Because of this fact, TORC2 may be involved in sphingolipid metabolism or signaling,
since the TORC2 effectors SLM1/2 (synthetic lethal with MSS4 1/2) are targets of sphingolipid
signaling during heat stress [150-153]. S. pombe Ste20 (orthologous to RICTOR and AVO3, but
different from S. cerevisiae STE20) binds Tor1 more strongly than Tor2 when it’s overexpressed
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[141], but in S. cerevisiae, Tor1 is a subunit of TORC2, which illustrates conservation of
function across species.
2.12 PAS Kinase in Yeast and Mammals
In 2001, two laboratories first recognized PAS kinase as a serine/threonine kinase with a
Per-Arnt-Sim (PAS) sensory domain that is similar to the sensory PAS domains commonly
found in bacteria, archaea, and plants (such as FixL, a bacterial oxygen sensor). They
hypothesized the importance of a protein kinase that could regulate many proteins and pathways
in response to cellular conditions. Both laboratories simultaneously cloned the PAS kinase gene
and performed initial characterization. Roland Wenger’s laboratory demonstrated ubiquitous
expression in mouse tissue, while Steven McKnight’s laboratory demonstrated regulation of the
kinase domain by the sensory N-terminal PAS domain [3]. This regulation in cis was further
characterized by Amazecua laboratory, who demonstrated the ability of the PAS domain to bind
specific ligands, which then removed the inhibition [5]. Unlike TOR (which is known to be
found in complexes), complexes required for PAS kinase function have yet to be discovered.

Table 2-4. A Summary of the Known In Vivo Effects of PAS Kinase in Yeast and Mammalian Cells.

Protein*

PASK

Mech.

Proinsulin,
Insulin
mGSK3ß

mPASK

UK

hPASK

DP

mSREB1c

mPASK

UK

scCbf1
mUSF1

Psk1

Apparent effect
Pancreatic Function
Ins2, Pdx2 decrease; Abnormal insulin
secretion
inactivation of mGSK3ß, decreased insulin
expression
Liver Function
decreased maturation and function;
decreased fatty acid synthesis
Respiration
inhibition of Cbf1 and increased
respiration
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Ref.
[167]
[168]
[169]
[170,
171]

Cell Differentiation
promotes myogenesis
Cell Wall Biosynthesis
increased UDP-glucose partitioning to cell
wall
Rho1 activation
Feeding/weight gain
altered activation in hypothalamus
altered activation in hypothalamus
Glycogen Storage
inactivation; decreased glycogen storage;

Wdr5

mPASK DP

scUgp1

Psk1/2

DP

scRho1

Psk2

UK

mAMPK
mTORC1

mPASK UK
mPASK UK

mGT1
scGsy2

hPASK, DP
Psk2
mRNA and Translational control
Psk2
binds
repression of ROK1 expression
5’UTR
hPASK, DP
activation and stress granule localization of
Psk1/2
Pbp1; altered Ataxin-2 protein levels
Psk2
DP
negatively regulates translation by
blocking the association of eIF4E and
eIF4G

scRok1
scPbp1
mAtxn2
scCAF20

[172]
[173,
174]
[16]
[175]
[175]
[168]
[176]
[15,
177]
[178]

*The abbreviation “sc” is for Saccharomyces cerevisiae, meaning that the data comes from studies with the
yeast proteins in yeast, while “m” is for mammalian proteins. DP is for direct phosphorylation, UK is
unknown. This table does not include in vitro substrates that have been identified but lack in vivo evidence.

2.13 The Regulation of PAS Kinase
In yeast, PAS kinase is activated by growth conditions that promote respiration (nonfermentative carbon sources), as well as by cell wall stress [179]. The activation of yeast PAS
kinase by respiratory conditions is thought to primarily occur via phosphorylation by the AMPK
ortholog in yeast termed SNF1 [15]. Mammalian PAS kinase also appears to be activated by
growth conditions that stimulate respiration (high glucose) in pancreatic ß-cell isolates [34].
PASK mRNA expression has also been shown to decrease in response to fasting and is
reactivated by feeding in mice. A study performed in Jared Rutter’s laboratory demonstrated
increased PASK mRNA expression upon re-feeding of either a normal chow or high-fat diet to
mice after a fast [169]. The decrease of PAS kinase mRNA upon fasting was recently confirmed
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in mice [180], along with increases in PASK mRNA expression upon re-feeding in
hypothalamus tissue [175] by the Elvira Alvarez laboratory. Thus, PAS kinase appears to be
regulated by nutritional status and cellular stress; it functions in a wide variety of pathways to
control metabolism in both yeast and mammalian systems [172] (a summary is found in Table 24).
2.14 The Functions of PAS Kinase in Mammals
2.14.1 Pancreatic Function. Guy Rutter’s laboratory was the first to demonstrate a role
for PAS kinase in pancreatic insulin production. PAS kinase depletion in clonal pancreatic cells resulted in abnormal proinsulin gene expression, with a corresponding decrease in Ins2 and
PDX1 gene expression [167]. Vincent Poitout’s laboratory confirmed a role for PAS kinase in
insulin production using cultured mouse and rat islets, where overexpression of PASK increased
insulin and PDX1 gene expression when islets were incubated with glucose and palmitate [181].
Expectedly, expression of kinase-dead PASK in these rat islets decreased insulin and PDX1 gene
expression. Jared Rutter’s laboratory reported PAS kinase-deficient mice (PASK-/-) displayed
impaired plasma insulin secretion upon glucose stimulation in the whole-animal as well as in
isolated islets [182]. In addition, they reported increased whole-animal insulin sensitivity.
These results were recently supported by a study from the Elvira Alvarez laboratory who
confirmed the increased insulin sensitivity in the PASK-/- mice [180]. Alternative but related
results for the PASK-/- whole-animal studies were reported by Guy Rutter’s laboratory, who
observed little effect on in vivo insulin secretion upon stimulation, but did observe a significant
decrease in total pancreatic insulin content as well as glucagon release. In order to further
investigate these effects on insulin, they created the first two tissue-specific knockouts – one in
pancreatic -cells and the other in -cells [183]. In the -cell knockout mice, no difference in
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weight gain or glucose/insulin tolerance was observed, however the -cell mass was increased,
and glucagon secretion was impaired at basal glucose levels as well as low glucose
concentrations (hypoglycemia). In contrast to this increase upon tissue-specific depletion of
PAS kinase, the -cell mass was decreased in the global PASK-/- knockout. In the -knockout
mice, no differences in weight gain were observed, however -cell mass was significantly
decreased upon either tissue-specific -cell knockout or global knockout in mice on both a
normal or high-fat (HF) diet. Furthermore, global knockout mice also displayed defects of in
vivo insulin secretion which were not observed in the -cell specific knockout, perhaps due to
whole-body development cues or downstream regulation from elsewhere in the body (the brain
or secreted hormones/nutrients from other tissues). From the studies in three different research
groups (Guy Rutter, Jared Rutter, and Elvira Alvarez laboratories), it was shown that PAS kinase
clearly affects insulin production and/or secretion, and is dependent on both nutritional and
whole-organism effects. However, there is one study from Roland Wenger’s lab where no
PASK-dependent insulin induction was observed, along with no changes in GTT or ITT. These
results could be due to the mouse construct or to a difference in diet.
Limited data on the effects of PAS kinase on pancreatic function in humans comes from a
study by Guy Rutter’s group on familial maturity onset diabetes of the young (MODY) [184].
This study identified two unrelated individuals with apparent MODY that harbored mutations in
PAS kinase. One mutation resulted in increased basal insulin hypersecretion (a 4.5-fold increase
in insulin release at low glucose) when expressed in mouse islets. Combined with the results in
mice, these findings support a role for PAS kinase in insulin and glucagon secretion, however,
this role may be nutrient-responsive, which explains differences in the observed phenotypes.
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The effect of PAS kinase on insulin secretion may be through the regulation of pancreatic
duodenal homoeobox-1 (PDX-1), a transcription factor that regulates the insulin promoter.
Vincent Poitout and Guy Rutter’s laboratory provided evidence for the PAS kinase-dependent
regulation of glycogen synthase kinase 3 (GSK3), which directly phosphorylates Pdx-1
triggering proteosomal degradation [185]. The direct phosphorylation of GSK3ß by PAS kinase
at Serine-9 leads to its inactivation in vitro. In addition, overexpression of PASK or kinase-dead
(KD) GSK3ß stabilizes Pdx-1 protein, while overexpression of knockdown PASK prevents
glucose-induction of insulin expression. Therefore, PAS kinase acts to inhibit GSK3ß, thereby
stabilizing Pdx-1 protein and promoting insulin expression.
2.14.2 Liver Function. One of the most dramatic phenotypes associated with PAS
kinase-deficient mice is the protection from hepatic liver triglyceride accumulation on a high-fat
(HF) or high-fat high-sugar (HFHS) diet. Jared Rutter’s laboratory reported complete protection
from hepatic lipid accumulation for male mice on the HF diet by enzymatic quantification [182],
which was recently confirmed in a study by the Elvira Alvarez laboratory [180]. We recently
reported a similar effect for male mice on the HFHS diet and further analyzed the triglycerides
through mass spectrometry [186]. PAS kinase appeared to reduce the accumulation of 25 of 44
triglycerides studied, and these 25 triglycerides made up a majority (90%) of triglycerides by
cellular abundance. Interestingly, the female mice had a decreased accumulation of triglycerides
independent of genotype, masking any significant effects from PAS kinase. These effects on
liver triglyceride accumulation were verified pharmacologically by Jared Rutter’s laboratory,
where inhibition of PAS kinase protected rats from liver triglyceride accumulation on a HF diet
[182]. Furthermore, they demonstrated that these effects may be due to the impaired SREBP- 1c
maturation observed in cultured HepG2 cells treated with shRNA or pharmacological inhibitors
37

of PAS kinase as well as in mouse and rat liver from pharmacologically-inhibited rodents [169].
SREBP-1c is a transcription factor implicated in the development of metabolic syndrome and
diabetes. It requires feeding-induced proteolytic maturation in the endoplasmic reticulum to
become an active nuclear transcription factor, therefore the reduction in maturation should
reduce fatty acid biosynthesis. Accordingly, the reduction of SREBP-1c maturation was
accompanied by decreased expression of SREBP-1c target genes including GPAT1, and Fasn in
pharmacologically treated rodents. We have recently provided evidence that Upstream
Stimulatory Factor 1 (USF1), a transcription factor intimately linked to SREBP-1c through coregulation of fatty acid biosynthesis, is also inhibited by PAS kinase in yeast [171]. In this case,
the inhibition is through direct phosphorylation. USF1 has been linked to human
hypertriglyceridemia in several Genome-Wide Association Studies (GWAS) [187]. Thus, the
effects of PAS kinase on both SREBP-1c and USF1 may account for the dramatic effects
observed in liver tissue.
2.14.3 Cellular Respiration. In the study of PASK-/- male mice on the HF diet performed
by Jared Rutter’s lab, the PASK-/- mice displayed a hypermetabolic phenotype in that they had a
higher whole-animal O2 uptake and CO2 output despite no significant difference in food intake or
activity (beam breaks) [182]. This hypermetabolic phenotype was supported by increased ATP
production from succinate in permeabilized soleus muscle fibers from PASK-/- mice, as well as
by shRNA silencing of PASK in L6-derived cells where increased [14C] glucose and [14C]
palmitate oxidation was observed. This apparent effect on respiration was recently confirmed by
our study of PASK-/- mice, where PASK-deficiency resulted in a 1.5-fold increase in soleus
tissue basal respiration independent of diet and sex [186]. In addition, PASK-/- male mice also
displayed a two-fold increase in oxidative phosphorylation capacity of soleus tissue when
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compared to the wildtype littermates. The effects of PAS kinase on respiration may be through
its substrate USF1, which is currently under investigation (see discussion of USF1 below).
2.14.4 Weight Gain. In addition to the resistance to insulin insensitivity and liver
triglyceride accumulation, PASK-/- male mice on the HF diet also displayed lower weights than
their wildtype littermates [182]. This may be partially due to hormonal effects, since the Elvira
Alvarez laboratory has reported effects of PAS kinase on hypothalamus function. In the
hypothalamus, PAS kinase is regulated by fasting/feeding and knockout of PAS kinase blunts the
exendin-4 feeding-based activation of AMPK and mTOR/e1.
2.14.5 Glycogen Storage. Human PAS kinase (hPASK) has also been shown to directly
phosphorylate and inactivate human glycogen synthase at a key regulatory residue, Serine 640
[168]. In addition, a study by Wayne Wilson, Peter Roach, and Jared Rutter, showed direct
interaction of hPASK with glycogen synthase in cultured cells, with disruption of this interaction
by glycogen itself.
2.14.6 mRNA Processing and Translational Control. The primary evidence for a role for
mammalian PAS kinase in regulating translation comes from a study by Roland Wenger’s
laboratory in which eukaryotic translation elongation factor eEF1A1 was identified as a substrate
and in vivo binding partner of mammalian PAS kinase [188].
2.14.7 Cell Differentiation. Jared Rutter’s lab recently discovered a role for PAS kinase
in promoting the differentiation of embryonic stem cells, as well as myogenic and adipogenic
progenitor cells [172]. This control of differentiation occurs through direct phosphorylation of
Wdr5, a subunit of histone H3 Lysine 4 trimethylase (H3K4me3), which stimulates myogene
gene expression via H3K4me3 marks on its promoter.
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2.15 The Functions of PAS Kinase in Yeast
Many of the phenotypes observed in the whole animal are mirrored in the single-celled
eukaryote Saccharomyces cerevisiae. As with TOR, some effects appear to be mediated by both
yeast PAS kinase paralogs (Psk1 and Psk2), while others appear to be specific.
2.15.1 Cellular Respiration. The effects of PAS kinase on respiration seen in mammalian
cells appear to be well conserved, since PAS kinase-deficiency increases respiration in yeast [15,
171]. This effect on respiration is at least partially due to the phosphorylation and inhibition of
Centromere-Binding Factor 1 (Cbf1) at Threonine-212, since CBF1-deficient yeast display
decreased respiration, the triple combination yeast (cbf1psk1psk2) show a reduction in
respiration, and a phosphosite mutant (T212A) displays increased respiration [171]. However,
the reduction of respiration is not complete in the triple knockout, suggesting alternative
pathways in the respiratory function of PAS kinase.
The CBF1-dependent regulation of respiration in yeast is at least in part to due to the
direct transcriptional regulation of the gamma subunit of ATP synthase (ATP3). ATP3 has a
known Cbf1-binding site in its promoter and is regulated by Cbf1 as demonstrated by both ß galactosidase and mass spectrometry analysis. In addition, we have shown that Cbf1 directly
regulates the expression of Psk1, thereby inhibiting its inhibitor.
Cbf1 is the only known substrate for which Psk1 and Psk2 appear to have different roles,
however, there is some evidence that Psk2 is the dominant kinase for Ugp1 phosphorylation (see
below). Psk2 only very weakly phosphorylates Cbf1 in vitro [171]. In addition, Psk2 has been
shown to have decreased activity (possibly through decreased expression) under respiratory
conditions, suggesting the contributions of PAS kinase under respiratory conditions are primarily
through Psk1 [179].
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The regulation of respiration by PAS kinase through the phosphorylation of Cbf1 may be
conserved in mammalian cells since, first, hPASK can phosphorylate USF1 (the mammalian
Cbf1-ortholog) in vitro, and second, USF1 can complement the respiration phenotype of Cbf1deficient yeast [171]. This is the first evidence that mammalian USF1 may have a role in
respiratory metabolism, in addition to its role in fatty acid biosynthesis.
2.15.2 mRNA Processing and Translational Control. Several findings have supported a
role for yeast PAS kinase in translational control. First, yeast Psk2 directly phosphorylates and
activates Cap-Associated Factor (CAF20), a phosphoprotein of the mRNA cap-binding complex
involved in translation control of mRNA expression [178]. CAF20 is an eIF4E-binding protein
that directly competes with eIF4G for binding to eIF4E, which association nucleates assembly of
the translational apparatus with the 5’ cap of mRNAs. Mammalian eIF4E-binding proteins (4EBPs) are a key point in translational control and are often regulated through phosphorylation.
Interestingly, in this same study by Steven McKnight’s lab, Psk2 was also found to
phosphorylate two other proteins in vitro which were involved in translational control, TIF11 and
SRO9. TIF11 is an essential translation initiation factor that forms a complex with eIF1 and the
40S ribosomal subunit, scanning for the initiating AUG. Sro9 binds RNA and interacts with
translating ribosomes. Many proteins involved in translation were also retrieved from a
psk1psk2 suppressor screen, and Psk2 overexpression suppresses the growth and protein
synthesis defects of eIF4B-deficient yeast. These effects on translation are consistent with the
phosphorylation of eEF1A1 by mammalian PAS kinase reported above. It is unknown whether
Psk1 also regulates CAF20 in yeast.
Both Psk1 and Psk2 phosphorylate and activate poly(A)-binding protein 1 (Pbp1) [15].
This phosphorylation leads to increased Pbp1 localization at stress granules. Pbp1, like its
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mammalian ortholog Ataxin-2, is known to recruit both mRNA and proteins (including yeast
TORC1) to stress granules, thereby inhibiting their expression and/or activity. In fact, deletion
of PSK1 and PSK2 suppresses the caffeine sensitivity seen in yeast overexpressing Pbp1,
suggesting rescue of TORC1 function. This was confirmed through SK1 immunoblot, a key
TORC1 substrate. We have recently demonstrated the in vitro phosphorylation of mammalian
Ataxin-2 by hPASK and have demonstrated the ability of Ataxin-2 to complement Pbp1 function
in yeast, including its apparent regulation by PAS kinase. This evidence suggests that this
pathway by which PAS kinase regulates TORC1 may be conserved.
A third pathway may tie PAS kinase to mRNA processing and translation through the
regulation of Rok1 mRNA [176]. In a three-hybrid screen, Psk2 was identified as a ROK1
5’UTR-interacting partner. In addition, overexpression of Psk2 repressed Rok1 protein
expression.
2.15.3 Cytoskeleton Polarization and Cell Wall Integrity. One of the best characterized
substrates of yeast PAS kinase is UDP-glucose pyrophosphorylase (UGP1) [178], which
catalyzes the reversible formation of UDP-glucose from glucose-1-phosphate and UTP. Ugp1
can be phosphorylated in vitro by both Psk1 and Psk2. Although the phosphorylation appears to
have no effect on its enzymatic activity, it alters where its product (UTP) is utilized, favoring cell
wall biosynthesis over glycogen storage [173]. Although it has not been demonstrated, it is
hypothesized that phosphorylation localizes UGP1 to the cell periphery, perhaps by altering
protein binding partners, thereby favoring UTP utilization for cell wall biosynthesis.
Accordingly, psk1psk2 yeast are sensitive to cell wall perturbing agents, and have increased
glycogen (this may also be due to phosphorylation of Gsy2). It is unknown whether the
phosphorylation of UGP1 by PAS kinase is conserved in mammalian cells.
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In addition to its role in cell wall biosynthesis through the phosphorylation of Ugp1,
overexpression of Psk2 is also capable of suppressing a tor2(ts) mutation through the activation
of Rho1 [189]. This suppression requires the Ssd1 protein, which interacts with TOR
components to play a role in the polarization of the cytoskeleton and cell wall integrity. In
addition, suppression requires phosphorylated Ugp1 and Rom2, which appear to form a signaling
complex with Ssd1 to activate RhoI. Psk1 overexpression does not appear to suppress the
tor2(ts) mutant, suggesting this role is primarily a Psk2 function. However, it is unknown
whether the mPASK is capable of suppressing defects in mTORC2.
2.15.4 Glycogen Storage. Similar to the regulation of mammalian glycogen synthase by
mammalian PAS kinase, yeast Psk2 phosphorylates and inactivates yeast glycogen synthase 2
(Gsy2). Psk2 directly phosphorylates Gsy2 in vitro at Serine-654, a key residue known to
influence inhibition. In addition, deletion of both Psk1 and Psk2 paralogs results in an increase
in glycogen synthase activity as well as a three to four-fold increase in glycogen accumulation
[178], although this accumulation seen in the double mutant is greater than either mutant alone; it
is unknown whether Psk1 can directly phosphorylate Gsy2.
2.16 Crosstalk Between PAS Kinase and TOR
PAS Kinase and TOR appear to have co-evolved to work together in the cell to regulate
various cellular processes (see Figure 2-3). PAS kinase and TOR have many overlaps in
function, including their roles in regulating translation initiation. The two paralogs in yeast PAS kinase and TOR - appear to have paired functions. One of the primary functions of TORC1
in yeast is to modulate translation initiation. TORC1 consists of either Tor1 or Tor2 together
with Kog1, Lst8 and Tco89. TORC1 is inhibited by both Psk1 and Psk2p through the
phosphorylation and activation of Pbp1, which in turn sequesters TORC1 to stress granules,
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inhibiting growth and proliferation [15]. In contrast, Psk2 regulates cell division (cytoskeleton
polarization and cell wall integrity) through the activation of RhoI, suppressing lethality due to
TORC2 deficiency [16]. Thus, both TOR and PAS kinase have overlapping functions for their
paralogs (Tor1 and Tor2, Psk1 and Psk2) in cell growth and proliferation, and specific functions
for Tor2 and Psk2 in cytoskeletal polarization and cell integrity. These roles for PAS kinase in
TORC1 regulation and the suppression of TORC2 deficiency by Psk2 remain unstudied in
mammalian cells.

Figure 2-3. PASK and TOR have Overlapping Functions.

2.17 Conclusions
The two paralogs of both PAS kinase and TOR have evolved to have unique functions in
the cell, while sharing some overlapping functions. This co-evolution has allowed for cells to
coordinate their efforts for a concerted action, such as protein synthesis/translation, mRNA
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processing, glucose homeostasis, respiration, cell differentiation, cellular signaling, cellular
proliferation, pancreatic function, etc.
Not only have the PASK and TOR paralogs evolved to have different functions, but the
entire TOR complex of proteins has co-evolved to control key cellular processes. The core
group of proteins is highly conserved, and depending on the organism and whether it is TOR
complex 1 or 2, non-conserved interactors may be involved. TORC1 is mainly responsible for
protein synthesis/ translation, mRNA processing, cell growth, nitrogen-catabolite repression, and
the retrograde response. TORC2 mostly regulates respiration, cellular differentiation, cellular
signaling, and cytoskeleton polarization, however, there are lots of overlaps in function between
the complexes, even in species as diverse as yeast and humans. TORC1 and TORC2 are both
known to contribute to the critical cellular processes of cell survival, cellular lifespan, and
various stress responses.
PAS kinase has evolved to work alongside TOR. PAS kinase and TOR have evolved to
coordinate and control the pathways of protein synthesis/translation, mRNA processing, glucose
homeostasis, respiration, cell differentiation, cellular signaling, and pancreatic function, while
PAS kinase also has its own unique functions of cell wall biosynthesis and proliferation,
glycogen storage, liver function, and feeding/ weight gain. Yeast Psk1 and Psk2 have also
evolved to have distinct, yet overlapping functions, as Psk1 has been found to control respiration
in yeast, while Psk2 affects glycogen storage. They are also capable of coordinating their efforts
in the regulation of cellular signaling. Even more interesting is that although TOR and PASK
have both evolved by gene duplication, Psk1 and Tor2 adapted related secondary functions that
Psk2 and Tor1 don't do, another indication of their co-evolution.
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As discussed earlier, both TOR and PASK have evolved to regulate respiration (see
Figure 2-4). When there is a low ATP:AMP ratio in the cell, AMPK is activated, which activates
Psk1. Psk1 then phosphorylates CBF1, which inhibits respiration (yeast preferentially ferment).
CBF1 also has the direct effect of upregulating ATP3 (an ATP synthase) in yeast. When there is
a high ATP:AMP ratio in the cell, AMPK is inhibited and TSC1/2 are free to inhibit Rheb, the
activator of mTOR. Once mTOR is activated, it upregulates the glycolytic enzyme PKM2 and
phosphorylates cPKC (important for glycogenolysis and gluconeogenesis) to increase cellular
respiration.

Figure 2-4. PAS Kinase and TOR have Co-evolved to Regulate the Critical Cellular Function of Respiration.

In the cellular proliferation pathway, PAS kinase and TOR work together to control cell
wall biosynthesis (see Figure 2-5). PAS kinase is activated by low energy or another stressor to
phosphorylate Pbp1 (ATXN2), which sequesters TORC1 to a stress granule and inactivates it,
thus decreasing cellular proliferation. On the other hand, when TORC1 is activated by Rheb in
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the lysosome, it activates ribosomal protein S6 kinase -1 (S6K1)1 and inactivates 4E-BP1,
thereby increasing translation and cell proliferation/ growth. When PAS kinase phosphorylates
Ugp1 in S. cerevisiae, it has the effect of increasing cell wall biosynthesis.

Figure 2-5. PAS Kinase and TOR have Co-evolved to Regulate the Critical Cellular Functions of Cellular
Proliferation and Growth.

As we continue to study the interactions and evolutionary history of these proteins, we
may begin to uncover new metabolic pathways and potential treatment targets for human
diseases that are controlled by these co-evolved proteins (such as cancer and diabetes). It may be
possible to identify downstream targets of these pathways, potentially allowing for a drug
treatment with fewer side effects than the current options.
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CHAPTER 3: Using DCA to Understand Kinase-Substrate Interactions
3.1 Importance of Protein Kinases
Protein kinases make up one of the largest and most important protein families. Because
of their evolutionary significance, kinase domains are highly conserved, with great sequence
homology existing in species as diverse as yeast and humans [190]. Even though protein kinase
genes constitute only about 2% of the genomes in most eukaryotes, they phosphorylate more
than 30% of cellular proteins [191]. By catalyzing the transfer of phosphate groups from ATP
(or GTP), kinases direct the activity and localization of many proteins, and are critical in the
regulation of nearly all cellular processes [192].
Protein kinases phosphorylate hundreds of downstream targets and control processes
from cell cycle progression to transcription and nervous system responses [193]. Tight
regulation of protein kinases is imperative because of all the critical functions they provide in the
cell; when they malfunction, diseases such as cancer [194-196], diabetes [196], or other
metabolic diseases may occur. In fact, Alzheimer’s Disease is believed to be caused by aberrant
protein kinases [197]. The brain has about six different isoforms of the tau microtubule-binding
protein, and when they are unphosphorylated, it inhibits their ability to bind microtubules and
prevents correct neuronal development and function. In short, when there isn’t a functional
protein kinase to phosphorylate the tau proteins, Alzheimer’s can result [198]. Because kinases
control so many cellular processes, protein kinases are often used as drug treatment targets.
Type 2 Diabetes, a disease marked by insulin resistance, is often treated with AMP-activated
kinase (AMPK) activators. AMPK plays a key role in the coordination of cellular energy
homeostasis, so when it malfunctions, diseases such as diabetes and cancer may result [23].
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From these examples, we can begin to understand the immense impact that kinases have
on our health, and the importance of studying them to provide better treatment options for people
afflicted with kinase-triggered diseases. Each year, billions of dollars are spent on laboratory
research [199], with many scientists trying to understand the in vivo functionality of the hundreds
of kinases in our bodies. We have discovered much about protein kinases using the current
standard procedure - co-immunoprecipitation and mass spectrometry - however, this method is
insufficient.
Notwithstanding the vital importance of protein kinases within the cell, they can be
difficult to study. Protein-kinase interactions are generally highly transient, so typical proteinprotein interaction discovery methods, such as co-immunoprecipitation and mass spectrometry,
rarely give the full “protein-kinase interaction picture.” In addition to the transient nature of
these interactions, there are often multiple sites which are phosphorylated on a target protein,
often by multiple kinases, so understanding the regulation and functions of these proteins can be
a difficult, but very important task because of the critical cellular processes involved. The sheer
number of proteins phosphorylated in the cell – 30-50%, depending on needs in the body – also
complicates the study of protein kinases [17]. The sheer quantity of kinases and their multitude
of targets makes them mechanistically difficult to study.
We are particularly interested in studying Per-Arnt-Sim (PAS) kinase because of its
significance in cellular metabolism. In a 2007 study [182], it was found that PAS kinaseknockout mice were hypermetabolic and more resistant to liver triglyceride accumulation than
the wildtype, despite having similar activity levels. Because of its tie to cellular metabolism,
PASK could potentially serve as a therapeutic target for cancer and diabetes. The common
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issues that occur in the study of nearly all protein kinases also, unsurprisingly, affect the study of
PAS kinase.
Kinases often induce conformational changes when they phosphorylate their substrates,
effectively “hiding” the phosphosite on the inside of the protein and potentially changing how
the substrate interacts with other proteins in the cell, including its location in the cell [18].
Structure affects function in proteins, so proteins are commonly crystallized to better understand
how they could interact with their substrates, however, large proteins such as PAS kinase are
difficult to crystallize [19]. In addition, kinases often phosphorylate multiple sites on its
substrates, and PAS kinase is no exception, making identifying the critical phosphorylation sites
difficult.
Because of the difficulty, we propose a novel method of studying protein kinases and
their phosphosites using Rice University’s Direct Coupling Analysis (DCA) algorithms [20] with
PAS kinase and five of its known substrates as a case study. Using DCA, the co-evolution of
PAS kinase with its confirmed substrates, Cbf1, Ugp1, Utr1 (three from yeast species), USF1,
and ATXN2 (two from mammalian species) is estimated by Mutual Information, allowing us to
predict the most likely interaction points, as well as potential phosphosites for the proteins. We
can potentially predict sites that are not captured by current kinase-study techniques, allowing us
to be more thorough in our research, and then use site-directed mutagenesis of the sites predicted
by DCA to confirm cellular effects caused by PAS kinase.
3.2 Methods
3.2.1 Direct Coupling Analysis. To collect sequences for the Direct Coupling Analysis,
we found organisms that had orthologs of both proteins of interest (for this study, yeast and
mammalian PAS kinase, yeast Cbf1, Ugp1, Utr1, and mammalian USF1 or ATXN2). For the S.
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cerevisiae DCA, we included other fungal species, and the H. sapiens analysis was limited to
other mammals. We used the longest isoform (see Table 3-1 for protein sequences) of Psk1 (for
fungal species) or hPASK (for mammalian species) and performed a regular protein BLAST to
find orthologs of the proteins in other species. To confirm that the listed protein was truly an
ortholog, we performed a non-organism-specific protein BLAST and checked that PASK was at
the top of the results. After verifying it was our protein of interest, we completed an organismspecific tBLASTn using organisms from the PASK BLAST search and the longest isoform of the
other protein of interest (Cbf1, Ugp1, Utr1, USF1, or ATXN2). We then downloaded the protein
alignments (starting with the smallest e-value) and re-BLASTed the proteins to confirm that it
was truly our protein of interest.

Table 3-1. Protein Sequences Used in Direct Coupling Analysis. The longest isoform of each protein from
H. sapiens (h) or S. cerevisiae (sc) was used.

Protein

Sequence

hPASK

MEDGGLTAFEEDQRCLSQSLPLPVSAEGPAAQTTAEPSRSFSSAHR
HLSRRNGLSRLCQSRTALSEDRWSSYCLSSLAAQNICTSKLHCPAA
PEHTDPSEPRGSVSCCSLLRGLSSGWSSPLLPAPVCNPNKAIFTVD
AKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSE
EHMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCC
VVVLEPVERVSTWVAFQSDGTVTSCDSLFAHLHGYVSGEDVAGQ
HITDLIPSVQLPPSGQHIPKNLKIQRSVGRARDGTTFPLSLKLKSQPS
SEEATTGEAAPVSGYRASVWVFCTISGLITLLPDGTIHGINHSFALT
LFGYGKTELLGKNITFLIPGFYSYMDLAYNSSLQLPDLASCLDVGN
ESGCGERTLDPWQGQDPAEGGQDPRINVVLAGGHVVPRDEIRKL
MESQDIFTGTQTELIAGGQLLSCLSPQPAPGVDNVPEGSLPVHGEQ
ALPKDQQITALGREEPVAIESPGQDLLGESRSEPVDVKPFASCEDS
EAPVPAEDGGSDAGMCGLCQKAQLERMGVSGPSGSDLWAGAAV
AKPQAKGQLAGGSLLMHCPCYGSEWGLWWRSQDLAPSPSGMAG
LSFGTPTLDEPWLGVENDREELQTCLIKEQLSQLSLAGALDVPHAE
LVPTECQAVTAPVSSCDLGGRDLCGGCTGSSSACYALATDLPGGL
EAVEAQEVDVNSFSWNLKELFFSDQTDQTSSNCSCATSELRETPSS
LAVGSDPDVGSLQEQGSCVLDDRELLLLTGTCVDLGQGRRFRESC
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scPsk1

hUSF1

VGHDPTEPLEVCLVSSEHYAASDRESPGHVPSTLDAGPEDTCPSAE
EPRLNVQVTSTPVIVMRGAAGLQREIQEGAYSGSCYHRDGLRLSI
QFEVRRVELQGPTPLFCCWLVKDLLHSQRDSAARTRLFLASLPGS
THSTAAELTGPSLVEVLRARPWFEEPPKAVELEGLAACEGEYSQK
YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE
DPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL
DLFAFIDRHPRLDEPLASYIFRQVRAGQSRLVSAVGYLRLKDIIHR
DIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL
MGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYL
VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE
EVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGPVPGEAP
NGQGCLHPGDPRLLTS
MPYIGASNLSEHSFVNLKEKHAITHKGTSSSVASLQTPPSPDQENHI
DNELENYDTSLSDVSTPNKKEGDEFEQSLRDTFASFRKTKPPPSLD
FEQPRLPSTASSSVDSTVSSPLTDEDIKELEFLPNESTHSYSYNPLSP
NSLAVRLRILKRSLEIIIQNPSMLLEPTPDDLPPLKEFAGRRSSLPRT
SASANHLMNRNKSQIWNTTSATLNAFVNNTSSSSAASSALSNKKP
GTPVFPNLDPTHSQTFHRANSLAYLPSILPEQDPLLKHNNSLFRGD
YGNNISPERPSFRQPFKDQTSNLRNSSLLNERAYQEDETFLPHHGP
SMDLLNEQRANLKSLLNLLNETLEKNTSERASDLHMISLFNLNKL
MLGDPKKNNSERDKRTEKLKKILLDSLAEPFFEHYNFIEDNPIADT
DELKEEIDEFTGSGDTTAITDIRPQQDYGRILRTFTSTKNSAPQAIFT
CSQEDPWQFRAANDLACLVFGISQNAIRALTLMDLIHTDSRNFVL
HKLLSTEGQEMVFTGEIIGIVQPETLSSSKVVWASFWAKRKNGLL
VCVFEKVPCDYVDVLLNLDEFGVENIVDKCELLSDGPTLSSSSTLS
LPKMASSPTGSKLEYSLERKILEKSYTKPTSTENRNGDENQLDGDS
HSEPSLSSSPVRTKKSVKFANDIKDVKSISQSLAKLMDDVRNGVVF
DPDDDLLPMPIKVCNHINETRYFTLNHLSYNIPCAVSSTVLEDELK
LKIHSLPYQAGLFIVDSHTLDIVSSNKSILKNMFGYHFAELVGKSIT
EIIPSFPKFLQFINDKYPALDITLHKNKGLVLTEHFFRKIQAEIMGDR
KSFYTSVGIDGLHRDGCEIKIDFQLRVMNSKVILLWVTHSRDVVFE
EYNTNPSQLKMLKESELSLMSSASSSASSSKKSSSRISTGTLKDMS
NLSTYEDLAHRTNKLKYEIGDDSRAHSQSTLSEQEQVPLENDKDS
GEMMLADPEMKHKLELARIYSRDKSQFVKEGNFKVDENLIISKISL
SPSTESLADSKSSGKGLSPLEEEKLIDENATENGLAGSPKDEDGIIM
TNKRGNQPVSTFLRTPEKNIGAQKHVKKFSDFVSLQKMGEGAYG
KVNLCIHKKNRYIVVIKMIFKERILVDTWVRDRKLGTIPSEIQIMAT
LNKKPHENILRLLDFFEDDDYYYIETPVHGETGCIDLFDLIEFKTN
MTEFEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSKGFVKII
DFGSAAYVKSGPFDVFVGTIDYAAPEVLGGNPYEGQPQDIWAIGI
LLYTVVFKENPFYNIDEILEGDLKFNNAEEVSEDCIELIKSILNRCV
PKRPTIDDINNDKWLVI
MKGQQKTAETEEGTVQIQEGAVATGEDPTSVAIASIQSAATFPDP
NVKYVFRTENGGQVMYRVIQVSEGQLDGQTEGTGAISGYPATQS
MTQAVIQGAFTSDDAVDTEGTAAETHYTYFPSTAVGDGAGGTTS
GSTAAVVTTQGSEALLGQATPPGTGQFFVMMSPQEVLQGGSQRSI
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hATXN2

scCbf1

scUtr1

APRTHPYSPKSEAPRTTRDEKRRAQHNEVERRRRDKINNWIVQLS
KIIPDCSMESTKSGQSKGGILSKACDYIQELRQSNHRLSEELQGLD
QLQLDNDVLRQQVEDLKNKNLLLRAQLRHHGLEVVIKNDSN
MRSAAAAPRSPAVATESRRFAAARWPGWRSLQRPARRSGRGGG
GAAPGPYPSAAPPPPGPGPPPSRQSSPPSASDCFGSNGNGGGAFRP
GSRRLLGLGGPPRPFVVLLLPLASPGAPPAAPTRASPLGARASPPRS
GVSLARPAPGCPRPACEPVYGPLTMSLKPQQQQQQQQQQQQQQQ
QQQQQQQQPPPAAANVRKPGGSGLLASPAAAPSPSSSSVSSSSAT
APSSVVAATSGGGRPGLGRGRNSNKGLPQSTISFDGIYANMRMVH
ILTSVVGSKCEVQVKNGGIYEGVFKTYSPKCDLVLDAAHEKSTES
SSGPKREEIMESILFKCSDFVVVQFKDMDSSYAKRDAFTDSAISAK
VNGEHKEKDLEPWDAGELTANEELEALENDVSNGWDPNDMFRY
NEENYGVVSTYDSSLSSYTVPLERDNSEEFLKREARANQLAEEIES
SAQYKARVALENDDRSEEEKYTAVQRNSSEREGHSINTRENKYIP
PGQRNREVISWGSGRQNSPRMGQPGSGSMPSRSTSHTSDFNPNSG
SDQRVVNGGVPWPSPCPSPSSRPPSRYQSGPNSLPPRAATPTRPPSR
PPSRPSRPPSHPSAHGSPAPVSTMPKRMSSEGPPRMSPKAQRHPRN
HRVSAGRGSISSGLEFVSHNPPSEAATPPVARTSPSGGTWSSVVSG
VPRLSPKTHRPRSPRQNSIGNTPSGPVLASPQAGIIPTEAVAMPIPA
ASPTPASPASNRAVTPSSEAKDSRLQDQRQNSPAGNKENIKPNETS
PSFSKAENKGISPVVSEHRKQIDDLKKFKNDFRLQPSSTSESMDQL
LNKNREGEKSRDLIKDKIEPSAKDSFIENSSSNCTSGSSKPNSPSISP
SILSNTEHKRGPEVTSQGVQTSSPACKQEKDDKEEKKDAAEQVRK
STLNPNAKEFNPRSFSQPKPSTTPTSPRPQAQPSPSMVGHQQPTPV
YTQPVCFAPNMMYPVPVSPGVQPLYPIPMTPMPVNQAKTYRAVP
NMPQQRQDQHHQSAMMHPASAAGPPIAATPPAYSTQYVAYSPQQ
FPNQPLVQHVPHYQSQHPHVYSPVIQGNARMMAPPTHAQPGLVS
SSATQYGAHEQTHAMYACPKLPYNKETSPSFYFAISTGSLAQQYA
HPNATLHPHTPHPQPSATPTGQQQSQHGGSHPAPSPVQHHQHQAA
QALHLASPQQQSAIYHAGLAPTPPSMTPASNTQSPQNSFPAAQQT
VFTIHPSHVQPAYTNPPHMAHVPQAHVQSGMVPSHPTAHAPMML
MTTQPPGGPQAALAQSALQPIPVSTTAHFPYMTHPSVQAHHQQQL
MNSLANNNKLSTEDEEIHSARKRGYNEEQNYSEARKKQRDQGLL
SQESNDGNIDSALLSEGATLKGTQSQYESGLTSNKDEKGSDDEDA
SVAEAAVAATVNYTDLIQGQEDSSDAHTSNQTNANGEHKDSLNG
ERAITPSNEGVKPNTSLEGMTSSPMESTQQSKNDMLIPLAEHDRGP
EHQQDDEDNDDADIDLKKDISMQPGRRGRKPTTLATTDEWKKQR
KDSHKEVERRRRENINTAINVLSDLLPVRESSKAAILACAAEYIQK
LKETDEANIEKWTLQKLLSEQNASQLASANEKLQEELGNAYKEIE
YMKRVLRKEGIEYEDMHTHKKQENERKSTRSDNPHEA
MKENDMNNGVDKWVNEEDGRNDHHNNNNNLMKKAMMNNEQI
DRTQDIDNAKEMLRKISSESSSRRSSLLNKDSSLVNGNANSGGGTS
INGTRGSSKSSNTHFQYASTAYGVRMLSKDISNTKVELDVENLMI
VTKLNDVSLYFLTRELVEWVLVHFPRVTVYVDSELKNSKKFAAG
ELCEDSKCRESRIKYWTKDFIREHDVFFDLVVTLGGDGTVLFVSSI
FQRHVPPVMSFSLGSLGFLTNFKFEHFREDLPRIMNHKIKTNLRLR
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scUgp1

LECTIYRRHRPEVDPNTGKKICVVEKLSTHHILNEVTIDRGPSPFLS
MLELYGDGSLMTVAQADGLIAATPTGSTAYSLSAGGSLVCPTVN
AIALTPICPHALSFRPIILPESINLKVKVSMKSRAPAWAAFDGKDRI
ELQKGDFITICASPYAFPTVEASPDEFINSISRQLNWNVREQQKSFT
HILSQKNQEKYAHEANKVRNQAEPLEVIRDKYSLEADATKENNN
GSDDESDDESVNCEACKLKPSSVPKPSQARFSV
MSTKKHTKTHSTYAFESNTNSVAASQMRNALNKLADSSKLDDAA
RAKFENELDSFFTLFRRYLVEKSSRTTLEWDKIKSPNPDEVVKYEII
SQQPENVSNLSKLAVLKLNGGLGTSMGCVGPKSVIEVREGNTFLD
LSVRQIEYLNRQYDSDVPLLLMNSFNTDKDTEHLIKKYSANRIRIR
SFNQSRFPRVYKDSLLPVPTEYDSPLDAWYPPGHGDLFESLHVSG
ELDALIAQGREILFVSNGDNLGATVDLKILNHMIETGAEYIMELTD
KTRADVKGGTLISYDGQVRLLEVAQVPKEHIDEFKNIRKFTNFNT
NNLWINLKAVKRLIESSNLEMEIIPNQKTITRDGHEINVLQLETACG
AAIRHFDGAHGVVVPRSRFLPVKTCSDLLLVKSDLFRLEHGSLKL
DPSRFGPNPLIKLGSHFKKVSGFNARIPHIPKIVELDHLTITGNVFLG
KDVTLRGTVIIVCSDGHKIDIPNGSILENVVVTGNLQILEH

After collecting sequences for separate fungal and mammalian DCAs, we performed a
multiple sequence alignment for each of the pairwise comparisons (PAS kinase vs. Cbf1, Ugp1,
Utr1, USF1, or ATXN2). Using the multiple sequence alignments, we performed DCA (see
Figure 3-1 for summary of process). We then extracted the residue numbers from the multiple
sequence alignment that correlated to the original residues in S. cerevisiae or H. sapiens. We
made a heatmap of DCA mutual information interactions. The brightest yellow color on the heat
map (with mutual information coefficients above 1.5) are indicative of the strongest interactions,
and greatest likelihood of co-evolution between proteins (see Figures 3-2 and 3-3).
3.2.2 Site-Directed Mutagenesis. To decide which residues to mutate via site-directed
mutagenesis, we sorted the raw data and examined the “pairings” with mutual information
coefficients above 1.4. The amino acid residues that appeared most frequently with the “above
1.4” cutoff were chosen for mutagenesis. In addition, potential phosphorylation sites were
identified as serines or threonines that had high mutual information coefficients, since we know
that PAS kinase is a serine/threonine kinase [200]). Site-directed mutagenesis was performed
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according to the QuickChange Mutagenesis protocol (StrateGene) using the primers listed in
Table 3-2. The resulting plasmid DNA was sequenced to confirm mutations.
Table 3-2. Primers Used for Site-Directed Mutagenesis of PAS Kinase Substrates.

Protein Mutation Forward Primer
H1161A CGT TGA ACA AAA AAC CAG CTG AGA ATA TTT TAC
GG
I1121A
AAG AAG AAT AGG TAT GCT GTG GTG ATT AAG ATG
Psk1
E880A
CGA GAG ACG TGG TAT TTG CAG AAT ATA ATA CAA
ATC C
V841A
GGC CAT CAA TAC CCA CCG CGC ACG TAT AAA AGC
E829A
GGA AAA TTC AGG CAG CGA TTA TGG GTG ATC G
P203A
CTT CCA CGA CGA CCC GCC TGC ATG CTT ATA TCC
R205A
GCA TGC AGC CGG GTG CTC GTG GAA GAA AAC CTA C
R252A
GAC CTC CTG CCC GTG GCA GAA TCA AGT AAG GCA G
Q304A
GTG CAA ATG AGA AAC TGG CGG AAG AAC TGG GAA
Cbf1
ATG C
L320A
GTA CAT GAA ACG CGT TGC AAG GAA GGA GGG AAT
AG
I325A
TTA AGG AAG GAG GGA GCA GAA TAC GAG GAT ATG
C
T419A
ATT TTA TAA CCA TAT GCG CCG GCC CAT ATG CTT
TTC CAA C
Utr1
T425A
CGG GCG AGG CTT CCA CGG CTG GAA AAG CAT ATG G
S451A
GAG GGA ACA ACA AAA GGC CTT TAC GCA TAT TTT
GTC CC
S186A
CCT AGG ACT CAC CCT TAT GCC CCG AAG TCA GAA
USF1
GCT CCC

Figure 3-1. Method for Performing Direct Coupling Analysis.
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3.3 Results
Direct coupling analysis was performed on yeast or mammalian PAS kinase compared
with yeast Cbf1, Ugp1, Utr1, or mammalian USF1, or ATXN2, respectively. The results are
provided in Figures 3-2 and 3-3. In most eukaryotic cells, only one PAS kinase can be
identified. However, there are two paralogs in yeast, Psk1 and Psk2, that appear to have arisen
via whole-genome duplication. A discussion of each of the substrates and the corresponding
DCA results follows.

Figure 3-2. Heat Maps Showing DCA Mutual Information of S. cerevisiae Psk1 vs. Ugp1, Cbf1, or Utr1. The
brightest yellow indicates a closer evolutionary relationship between the amino acid residues of the two proteins.

Figure 3-3. Heat Maps Showing DCA Mutual Information of H. sapiens PASK vs. USF1 or ATXN2. The brightest
yellow indicates a closer evolutionary relationship between the amino acid residues of the two proteins.
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3.3.1 Ugp1 and PSK. UDP-glucose pyrophosphorylase 1 (Ugp1) is the best characterized
substrate of yeast PAS kinase (PSK), so it was used as a control for these studies. Ugp1 was first
discovered as a substrate by Rutter, et al. in 2002 through in vitro kinase screens of yeast
proteins [174]. It has since been shown be phosphorylated in vivo at Serine-11 [173]. Ugp1
phosphorylates the reversible conversion of glucose 1-phosphate and UDP-glucose to uridine
triphosphate (UTP), a cellular glucose storage molecule [201]. Phosphorylation by either yeast
paralog, Psk1 or Psk2, does not result in a change in enzymatic activity, but rather a change in
the destination of its substrate UTP. Phosphorylation of Ugp1 results in increased cell wall
components and decreased glycogen storage [179]. In contrast, PAS kinase-deficient yeast
(psk1psk2) or yeast harboring the phosphosite mutant of Ugp1 (S11A) display increased
glycogen [174] and are sensitive to cell wall perturbing agents [173]. Interestingly, the DCA
results show the highest mutual association probabilities at the N-terminus of Ugp1, particularly
amino acids 1-80 (Figure 3-2A, Table 3-2). These results are consistent with the known
phosphorylation site at Serine-11, providing proof-of-principle. No further studies can be easily
conducted with this protein to confirm important kinase-substrate interaction residues since we
are unable to tag Ugp1 in any way without disrupting the PSK-Ugp1 interaction [173].

Table 3-3. Trending Amino Acids for Each Protein. The trending amino acids with the best Mutual
Information (i.e. a coefficient above 1.4, or above 0.5 for USF1) were identified. The residues with the
greatest Mutual Information coefficients are listed in descending order for each protein. Potential
phosphosites or interaction sites were noted.

Protein
Ugp1

Trending Residue #

Amino Acid

38
89
3
206

S
near S
T
S
57

Potential
Phosphosite /
Interaction Site
phosphosite
phosphosite
phosphosite
phosphosite

Cbf1

Utr1

USF1

ATXN2

1
2
88
392
5
94
252
205
321
203
251
304
320
467
90
470
475
85
91
474
86
472
159
7
174
132
58
129
276
307
47
59
121
481
614
684
489
678
63
472
731
687
706

near S
S
Y
near S
near S
near S
near S
near S and T
R
near S
near S
E
L
E
near S and T
K
A
near S
T
Q
T
R
near T
T
S
T
Q
near T
D
near S
V
V
S
near S
near S and T
S
near T
S
near S
T
near S and T
T
V
58

phosphosite
phosphosite
interaction site
phosphosite
phosphosite
phosphosite
phosphosite
phosphosite
interaction site
phosphosite
phosphosite
interaction site
interaction site
interaction site
phosphosite
interaction site
interaction site
phosphosite
phosphosite
interaction site
phosphosite
interaction site
phosphosite
phosphosite
phosphosite
phosphosite
interaction site
phosphosite
interaction site
phosphosite
interaction site
interaction site
phosphosite
phosphosite
phosphosite
phosphosite
phosphosite
phosphosite
phosphosite
phosphosite
phosphosite
phosphosite
interaction site

3.3.2 Cbf1 and PSK. Centromere binding factor 1 (Cbf1) was identified as a yeast twohybrid partner and an in vitro substrate of Psk1 in 2014 by DeMille, et al. [177], and was
recently characterized. Cbf1 and Psk1 strongly interacted in the yeast two-hybrid screen, which
allowed us to test residues that were expected to be important for the Psk1-Cbf1 interaction. We
found that Cbf1 is preferentially phosphorylated by Psk1 (only weakly by Psk2) at Threonine212, and controls cellular respiration and lipid biosynthesis in yeast [186]. The Cbf1 residues
with the highest mutual information occur around the region of phosphorylation (T212, Figure 32B, Table 3-3), once again confirming the validity of DCA as a method of determining potential
interaction sites between proteins.
3.3.3 Utr1 and PSK. NAD kinase (Utr1) was identified as a yeast two-hybrid partner and
an in vitro substrate of Psk1 in 2014 by DeMille et al. [177], and is the least characterized
substrate used in this analysis. The DCA results suggest the region of phosphorylation is near
amino acid 480, or amino acid 90 (both are regions with high mutual association coefficients).
We performed mass spectrometry analysis of Utr1 incubated with PAS kinase, which identified
two putative phosphorylation sites: Threonine-419 and Threonine-425 (unpublished data).
Although protein kinase substrates do not always obey a consensus, there is also one putative
phosphorylation site matching the PAS kinase phosphorylation consensus (Strong preference for
R/H/K at -3 and/or -5 position, some preference for S/T/C/P/N/Q at the -2 position [19]) in this
region – Serine 451 (REQQKS*). These constructs have been made and will be tested via in
vitro kinase assay for their validity.
3.3.4 USF1 and PASK. Upstream Stimulatory Factor 1 (USF1) is the human ortholog of
yeast Cbf1, which has been shown to be a substrate of yeast PAS kinase. USF1 has been
associated with hyperlipidemia in several Genome-Wide Association Studies (GWAS) [20259

204]. Thus, the regulation of USF1 by PAS kinase may explain the dramatic decrease in
triglyceride accumulation observed in PAS kinase-deficient mice [182]. In support of the
conservation of regulation and function, human USF1 expression can complement the respiration
defect observed in CBF1-deficient yeast and appears to be regulated by PAS kinase in yeast
[186]. In addition, human PAS kinase can phosphorylate USF1 in vitro. To test this association,
as well as aid in phosphosite mapping, the evolutionary association of USF1 and PAS kinase was
explored through DCA (Figure 3-3A). Although the overall association plot is much darker than
other substrates, there is a clear association in the region around amino acid 130. Interestingly,
when searching for PAS kinase consensus sequences, there is an excellent match at amino acid
186 (RTHPYS*), a smaller, but also bright, nearby region on the DCA heat map. This amino
acid has been mutated to an alanine (S11A) and will be tested as a putative phosphosite in the in
vitro kinase assays.
3.3.5 ATXN2 and PASK. There is also preliminary data to support Ataxin-2 (ATXN2) as
a substrate of mammalian PAS kinase. Human mutations in Ataxin-2 are associated with
Amyotrophic Lateral Sclerosis (ALS), a devastating neurodegenerative disease that affects
nerves of the brain and spinal cord. The yeast ortholog of ATXN2 (Poly(A)- Binding Protein, or
Pbp1) was first identified as a yeast two-hybrid partner and in vitro substrate of Psk1 in 2014 by
DeMille et al. [177], and was subsequently shown to be activated by PAS kinase in vivo [15].
We have recently demonstrated the ability of human ATXN2 to complement yeast Pbp1 and
have provided evidence for the regulation of ATXN2 by PAS kinase in yeast. In addition,
human PAS kinase can phosphorylate ATXN2 in vitro. Despite the clear importance of this
substrate, we have been unable to map the critical phosphorylation site by mass spectrometry;
over 10 sites were identified, but none appeared to be the critical site for PAS kinase
60

phosphorylation (unpublished data). This may be due to the presence of other kinases that
phosphorylate Pbp1, as we have previously provided evidence for these unknown kinases [205].
We therefore attempted to perform DCA on both the yeast proteins (Psk1 and Pbp1) as well as
their human orthologs (PASK and ATXN2). The abundance of Pbp1 orthologs (which lacked a
matching organism for PSK1) made the analysis of the fungi difficult, however, we were able to
get data on the mammalian orthologs. As seen in Figure 3-3B, there are multiple regions of
association between these proteins with two key regions around amino acids 480 and 615 of
ATXN2 (Figure 3-4). There are PAS kinase consensus sequences near each of these two
regions. There is a consensus sequence at Serine 479 (VQRNSS*) and a consensus at 617
(PKRMSS*), both of which are currently being mutated to check for their requirement through
in vitro kinase assays. A double mutant with both mutations is also being constructed, since this
dual phosphorylation may be the reason for the abundance of phosphorylation events seen by
mass spectrometry.

Figure 3-4. A Diagram Depicting the hATXN2 and hPASK Trending Amino Acids.
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3.3.6 PASK and its substrates. In addition to identifying critical substrate residues for
PAS kinase-substrate interactions, our DCA results also suggest regions of PAS kinase that may
be important for substrate recognition. PAS kinase contains a regulatory PAS domain, which is
thought to bind the kinase domain and inhibit its activity (Figure 3-5). When a small molecule
binds the PAS domain or PAS kinase is phosphorylated, it disrupts the interaction between the
PAS and kinase domains, thus activating PAS kinase and allowing it to phosphorylate its
substrates. Most protein kinases that function in larger complexes are composed of regulatory
subunits and/or substrate-recognition subunits, in addition to the catalytic kinase subunit. We
hypothesize that the large middle region of PAS kinase may function as the substrate recognition
module of PAS kinase. Our DCA results support this hypothesis, since the residues with the
greatest mutual information values are located between the PAS and kinase domains (for
example, see Figure 3-4). To confirm this hypothesis, we have mutated several of these residues
in Psk1 and will test the ability of PAS kinase to recognize and bind its substrates via the yeast
two-hybrid.

Figure 3-5. Activation of PAS Kinase. A small metabolite binds the PAS domain or PAS kinase is
phosphorylated, disrupting the interaction between the PAS and kinase domains, thus activating PAS kinase
and allowing it to phosphorylate its substrates.
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3.4 Conclusions
By exploring the interactions of Per-Arnt-Sim (PAS) kinase with several of its substrates
via Direct Coupling Analysis (DCA) and subsequent kinase assays, it will allow us to determine
important phosphosites of the substrates, as well as critical substrate recognition sites on PAS
kinase. We have already identified several sites of interest in our data, generated several
constructs, and we will be testing the interactions between PAS kinase and yeast Cbf1, Utr1,
Ugp1, and mammalian USF1 or ATXN2. As we understand more about PAS kinase and the
proteins and pathways that it regulates, we could potentially find new therapeutic treatment
targets for metabolic diseases, such as: ALS, diabetes, hyperlipidemia, hypercholesterolemia, or
cancer.
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